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ABSTRACT OF DISSERTATION

REGULATION OF L-TYPE VOLTAGE-DEPENDNET CALCIUM
CHANNELS BY THE REM GTPASE
The Rem, Rem2, Rad, and Gem/Kir GTPases, comprise a novel subfamily of the
small Ras-related GTP-binding proteins known as the RGK GTPases, and have been
shown to function as potent negative regulators of high voltage-activated (HVA) Ca2+
channels upon overexpression. HVA Ca2+ channels modulate Ca2+ influx in response to
membrane depolarization to regulate a wide variety of cellular functions and they
minimally consist of a pore-forming α1 subunit, an intracellular β subunit, and a
transmembrane complex α2/δ subunit. While the mechanisms underlying RGK-mediated
Ca2+ channel regulation remain poorly defined, it appears that both membrane
localization and the binding of accessory Ca2+ channel β subunits (CaVβ) are required for
suppression of Ca2+ channel currents. We identified a direct interaction between Rem and
the L-type Cavα1 C-terminus (CCT), but not the CCT from CaV3.2 T-type channels.
Deletion mapping studies suggest that the conserved CB-IQ domain is required for
Rem:CCT association, a region known to contribute to both Ca2+-dependent channel
inactivation and facilitation through interactions of Ca2+-bound calmodulin (CaM) with
the proximal CCT. Furthermore, both Rem2 and Rad GTPases display similar patterns of
CCT binding, suggesting that CCT represents a common binding partner for all RGK
proteins. While previous studies have found that association of the Rem C-terminus with
the plasma membrane is required for channel inhibition, it is not required for CaVβsubunit binding. However, Rem:CCT association is well correlated with the plasma
membrane localization of Rem and more importantly, Rem-mediated channel inhibition
upon overexpression. Moreover, co-expression of the proximal CB-IQ containing region
of CCT (residues 1507-1669) in HIT-T15 cells partially relieves Rem blockade of ionic
current. Interestingly, Ca2+/CaM disrupts Rem:CCT association in vitro. Moreover, CaM
overexpression partially relieves Rem-mediated L-type Ca2+ channel inhibition and Rem
overexpression alters the kinetics of calcium-dependent inactivation. Together, these data
suggest that the association of Rem with the CCT represents a crucial molecular
determinant for Rem-mediated L-type Ca2+ channel regulation and provides new insights
into this novel channel regulatory process. These studies also suggest that instead of

acting as complete Ca2+ channel blockers, RGK proteins may function as endogenous
regulators for the channel inactivation machinery.
Keywords: RGK GTPase, Voltage-dependent calcium channels, Cavα1 C-terminus (CCT),
Calmodulin, Calcium-dependent inactivation
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Chapter 1. RGK GTPases: Regulators of Cytoskeleton Reorganization
and Voltage-Dependent Calcium Channels
1. 1 Introduction
As essential players in orchestrating the signaling pathways in a wide spectrum of
normal physiology, the Ras GTPases are monomeric small GTP-binding proteins
consisting of approximately 170 members [1]. Based on their structural and functional
similarities, these proteins have been classified into Ras, Rab, Rho, Arf, and Ran families
[1]. The members of each family can be further subdivided into evolutionarily conserved
subfamilies, reflecting additional levels of structural, biochemical, and functional
conservation [1]. All Ras-related GTPases contain five highly conserved domains (G1G5) [2]. The activity of Ras proteins is regulated by two major classes of regulatory
proteins, guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins
(GAPs) [2]. GEFs can facilitate the release of GDP, promoting the activation of Ras
GTPases through the binding of GTP. In contrast, GAPs enhance the hydrolysis of GTP
to GDP, leading to rapid inactivation [2]. The relative proportions of molecules in the
active and inactive conformation are tightly regulated by GEFs and GAPs. GTP binding
to Ras proteins triggers a major conformational change, which exposes amino acids in the
G2 domain (effector domain) so that a variety of intracellular proteins (effector proteins)
can interact with this domain to initiate an array of signal transduction cascades that
contribute to almost every aspect of cellular physiology, including cell proliferation,
differentiation, cytoskeleton reorganization, vesicular and nuclear transport, and most
recently in the regulation of voltage-dependent calcium channel function [1].
The RGK (Rem, Rem2, Rad and Gem/Kir) subfamily of small GTP-binding
proteins is comprised of four members, Rem (also known as Rem1 or Ges), Rem2, Rad,
and Gem (mouse homolog also referred to as Kir) that share unique structural features
that distinguish them from the other Ras proteins [3-9]. These include an extended
variable N-terminal domain with unknown function, several nonconservative
substitutions within the core domain known to be involved in both GTP/GDP binding and
hydrolysis in Ras GTPase, an extended and conserved C-terminal domain that directs the
RGK proteins to the plasma membrane but also serves as a target for intracellular
1

regulatory proteins. The fact that RGK proteins differ from one another and other Rasrelated proteins within their putative effector (G2) domains suggests that they likely
interact with distinct regulatory and effector proteins. Members of the RGK family are
expressed in a tissue-specific manner. Gem mRNA is expressed in the kidney, lung and
spleen [5]; Rad mRNA is expressed in both cardiac and skeletal muscle and within the
lung [6]; Rem mRNA is found in both cardiac and skeletal muscle, lung and kidney [3];
whereas Rem2 is the only RGK protein highly expressed within the central nervous
systems [4]. While classical GEFs and GAPs have not been identified for the RGK
GTPases (see chapter 1.2), additional approaches to their regulation have been shown, to
occur at both the transcriptional and posttranscriptional level (see chapter 1.4). Two
major functions of RGK proteins have been reported. Firstly, RGK proteins have been
shown to regulate actin cytoskeleton reorganization by interfering with the Rho/Rho
kinase signaling cascade; Secondly, RGK proteins have been reported to function as
potent negative regulators of voltage-dependent Ca2+ channel (VDCC) activity by
interacting with their accessory β-subunits (see chapter 1.6.6). My dissertation focuses on
addressing the molecular mechanisms underling Rem-mediated L-type Ca2+ channel
regulation. This is because RGK proteins have been suggested to help maintain normal
function in a variety of tissues and deregulation of RGK expression has been implicated
in several different diseases, including heart failure [10], arrhythmias [11] and diabetes
[6]. In this chapter, the structural and functional properties of the RGK proteins and the
mechanisms for controlling RGK protein function including phosphorylation, regulatory
protein binding, and lipid interactions will be discussed. The two major functions of RGK
proteins will be described and the proposed mechanisms for these regulatory processes
will be discussed.

1.2 RGK proteins are guanine nucleotide-binding proteins
The majority of Ras superfamily GTPases display five well conserved (G1 to G5)
core domains and several amino acids within these regions play critical roles in directing
both nucleotide binding and GTP hydrolysis [1]. However, RGK proteins contain a
number of non-conserved amino acid substitutions at multiple positions within these core
domains [3-9]. For example, RGK GTPases contain substitutions within the G1 motif that
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is involved in phosphate binding. The residue equivalent to Gly12 in Ras, mutation of
which results in the constitutive activation of both Ras and Rho family GTPases, is
altered in all RGK proteins (to Gln in Gem, Ser in Rem2, and Pro in Rad and Rem).
There are also major substitutions within the G2 and G3 domains, which function to
sense the gamma phosphate during GTP binding and promote conformational change
within Ras family proteins during their GTP/GDP activation cycle [3-8]. The highly
conserved threonine residue within G2 domain (Thr35 in Ras) is substituted by glutamate
in all of the RGK proteins. The G2 domain is the effector domain functioning as the
primary downstream effector protein anchoring site and is highly conserved within Ras
GTPase subfamilies. However, the sequence is highly divergent within this domain
among the four RGK proteins. This suggests the possibility that different RGK proteins
either associate with distinct cellular effectors, or perhaps that the RGK effector domain
involves residues beyond the canonical switch I and switch II regions (see chapter1.3).
All RGK proteins share a conserved DXWEX G3 motif which diverges significantly
from the DTAGQ motif found in other Ras family GTPases [12]. Particularly, the
glutamine residue (Gln61 in H-Ras), which plays a critical role in catalyzing GTP
hydrolysis, is conserved in Rad and Rem2 but is replaced by alanine in Rem and
asparagine in Gem. Despite these structural alterations, biochemical studies have revealed
that all RGK proteins display micromolar affinity for GDP and GTP, which is
considerably lower when compared with H-Ras. Importantly, all RGK proteins exhibit
intrinsic GTPase activity [3-9, 13-15]. However, the fact that RGK proteins exhibit
primary structural alterations when compared with the other Ras superfamily members
suggests that the mechanism of RGK-mediated GTP hydrolysis maybe unique.
Because RGK proteins are bona fide GTPases which are capable of alternating
between a GTP and a GDP-bound state, it is predicted that they will be regulated by the
actions of both GEF and GAP proteins. While these proteins have not yet been identified
for RGK GTPases, the in vitro GTP/GDP state of Rad has been found to be modified by
the tumor suppressor nm23, which can either phosphorylate GDP or dephosphoryate GTP
while the nucleotide is bound to Rad [16]. Therefore, functionally, nm23 can act as either
a GEF or a GAP for Rad. It remains to be determined whether nm23 functions as an in
vivo regulator of Rad, or regulates the actions of other RGK proteins. In addition to
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nm23, calmodulin was proposed to inhibit GTP binding to Gem [17]. In contrast, a recent
study also reported that calmodulin binding to Gem C-terminus does not affect the
kinetics of the nucleotide binding and dissociation, nor does it affect the GTPase activity
of Gem [8]. Indeed, it remains unclear whether the in vivo nucleotide status of RGK
proteins is regulated in response to extracellular stimuli, or if GTP-binding is required for
RGK downstream signaling. Therefore, the identification of RGK regulatory factors and
RGK downstream targets remains an important goal for the field. Isolation of GEF/GAP
proteins specific for RGK proteins may assist in the identification of the physiological
stimuli that control RGK G-protein activation.

1.3 RGK Structure
The crystal structures of GDP-bound Rad and Gem have been resolved recently
and it has been demonstrated that the RGK proteins adopt a canonical GDP-binding
domain (G-domain) fold similar to those found in other Ras family members [7-9].
However, because of the amino acid substitutions discussed above, fewer contacts with
the bound guanine nucleotide are observed [7-9] and in contrast to Ras, whose switch I
(G2 domain) covers the bound nucleotide, the same domain in Gem folds in a way which
leaves the nucleotide exposed [7, 8]. Interestingly, a portion of the extended Gem Cterminus makes contacts with the core G-domain, reminiscent of that seen with the Ntermini of GDP-bound Arf proteins [8, 18] and the C-terminus of Ran [19]. This
combination of structural alterations likely results in the lower GTP/GDP affinity found
for RGK proteins when compared to Ras [4, 8]. De Gunzburg and colleagues also
reported that the GTPase activity of Gem is reduced by removal of the N-terminus, or
following deletion of both the N- and C-terminal extensions from the conserved GTPase
core [8]. Together with the structural studies, these biochemical data suggest that
conformational changes involving rearrangement of the N- and C-termini might play an
important role in the RGK GTPase cycle, and indicate that the molecular mechanism of
RGK GTPase activity may be quite different from that of other small GTP-binding
proteins [8]. Additional crystal structures, particularly of full length RGK proteins in the
GTP-bound structural state, will be needed to further clarify this potentially novel
GTPase cycle.
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The crystal structures combined with in vitro binding studies have recently been
used to facilitate our understanding of the functional significance in both Gem-CaVβ [7,
20] and the Gem-Rho kinase interactions [7]. Interestingly, mutations of residues in
distinct regions of Gem were found to disrupt CaVβ association [7, 20]. Mutations of
residues within the G2 and G3 regions have been shown to be able to inhibit CaVβ
binding but not affect Gem-Rho kinase mediated neurite outgrowth [7], indicating that
the CaVβ and Rho kinase binding domains on Gem may be structurally distinct. A recent
study utilizing molecular modeling in combination with immunoprecipitation analysis
proposed that residues in the G4-G5 region of all RGK proteins constitute a novel
effector domain to direct CaVβ binding which is required for their functional regulation of
voltage-dependent calcium channels activity [20]. Although these data suggest that
multiple contact sites contribute to these interactions, and appear to involve residues
outside of the classical G2 effector loop, the functional consequences of these mutations,
especially those mutations which disrupt CaVβ binding, have not been examined. Thus,
the picture of how RGK proteins interact with their binding partners has begun to be
clarified, although resolution of the details of protein association awaits co-crystallization
studies.

1.4 Regulation of RGK Activity
The canonical way that the majority of Ras-related GTP-binding proteins are
activated is by releasing of GDP and binding of GTP with the aid of selective GEFs.
When their functional consequences have been accomplished, those GTPases will be
inactivated by hydrolyzing the bound GTP to GDP with the assistance of specific GAPs
[21]. Since it remains unclear whether RGK protein function is controlled via a classical
GTP/GDP cycle (see chapter 1.2) and intracellular GEFs or GAPs have not been
identified, a critical question is how RGK protein functions are regulated? While
definitive answers await additional study, it appears that both transcriptional and posttranslational control is involved in regulating RGK protein expression. Furthermore, the
C-terminus has emerged as a key regulatory domain being subject to phosphorylation, as
well as protein-protein and protein-lipid interactions, to control both the subcellular
localization and activity of all RGK GTPases.

5

1.4.1 Transcriptional regulation
Unlike the other members of Ras GTPase, a unique feature of RGK proteins is
their ability to be transcriptionally regulated [3, 5, 6, 13, 22-39]. In fact, Gem/Kir was
discovered as a gene upregulated in human T cells upon stimulation with mitogens [5] or
in BCR-Abl-transformed B cells [13]. Subsequent studies have found Gem is inducible
following inflammatory cytokine stimulation in endothelial cells [38] and is responsive to
muscarinic receptor agonists in neuroblastoma cell lines [28]. Gem has also been shown
to be upregulated during acute inflammation stimulation in human endothelial cells [39],
and in the brains of tau-deficient mice [31]. Finally, Gem/Kir expression has been
correlated with cell invasiveness [40], a key feature of metastatic cancer. Those studies
pointed out the potential role of Gem in regulating metastatic or inflammatory processes
upon extracellular stimuli.
In addition to Gem/Kir, Rad GTPase has also been demonstrated to undergo
transcriptional regulation in a variety of muscle cell types. Indeed Rad (Ras associated
with diabetes) was initially identified as a gene overexpressed in the skeletal muscle of
patients with type II diabetes [6], although subsequent studies in Pima Indians and the
Zucker diabetic rat model imply that this effect is not universal [41]. Insulin has also been
shown to enhance Rad mRNA levels in muscle [27], therefore, the upregulation of Rad
observed in these diabetic conditions may result from the high concentration of insulin
associated with the disease [42]. In addition, Rad expression is upregulated in both
developing and post-amputation de-differentiating muscle cells in the newt [35]. A
similar regulation is also observed in developing and regenerating muscle [22, 26], as
well as in denervated or injured muscle [22, 29], and in vascular smooth muscle cells
following balloon injury [23]. While the majority of Rad transcriptional regulation has
been reported in muscle, other intriguing observations have emerged from other cell
types. For instance, Rad is upregulated in human peripheral blood mononuclear cells after
acute heat shock [36] and in human placenta post-hypoxia [24, 33]. Rad expression is
also correlated with the grade, size, and metastatic potential of breast cancer tumors [37].
Less is known concerning the regulation of Rem and Rem2 genes. Rem2
expression is induced by high concentrations of glucose in a pancreatic β-islet cell line
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and overexpression of Rem2 prevents glucose-stimulated insulin secretion in pancreatic
beta-cell lines, presumably by inhibiting L-type Ca2+ channel activity [25]..Similarly,
Gem/Kir expression is induced in the same cell line in response to elevated glucose, or
following insulin and KCl treatment [30]. This suggests these RGK proteins could be
upregulated to function in a negative feedback pathway to prevent Ca2+ overload. Rem2
is upregulated in developing neurons and the development and maturation of
glutamatergic and GABAergic synapses is inhibited after the SiRNA-mediated Rem2
knockdown [32]. Therefore, Rem2 appears crucial for synapse development and
maturation, which is not too surprising since Rem2 is the only RGK protein abundantly
expressed in the central nervous system [4]. Finally, Rem expression is increased in
cardiomyocytes following treatment with isoproterenol, a β-adrenergic receptor agonist
[34], but decreased in cardiac muscle upon injection of mice with lipopolysaccharide, a
potent activator of the inflammatory and immune systems [3]. While these results are
intriguing, the physiological relevance of RGK transcriptional regulation is still unclear.
However, if RGK proteins are endogenous inhibitors for L-type Ca2+ channels activity in
native systems, RGK signaling may control a previously unappreciated negative feedback
cascade operating to protect both pancreatic β-cells (Rem2) and cardiomyocytes (Rem,
Rad) from uncontrolled Ca2+ signaling in the presence of persistent hyperglycemia or
chronic β-adrenergic stimulation [25, 34]. Since disruption of intracellular Ca2+
homeostasis readily induces cellular dysfunction, these putative pathways may play a
significant protective role against Ca2+ overloading in normal conditions. Overall, RGK
GTPases are found to be upregulated in both developmental and disease processes and
also during adaptive responses to extracellular stimuli.
1.4.2 Post-translational modification
For RGK proteins, the primary post-translational modification known up to the
present is phosphorylation. Phosphorylation has been shown to regulate the intracellular
localization/trafficking of RGK proteins as well as modulate their interactions with
different binding partners. For example, Rad has been shown to be phosphorylated by
several kinases, including PKA, PKC, CaMKII, and casein kinase II in vitro [14], and
these kinases are capable of phosphorylating several distinct serine residues within Rad.
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Although the physiological relevance of these phosphorylation events is not clear,
phosphorylation of Rad by PKC and casein kinase II have been shown to disrupt the
interaction between Rad and calmodulin in vitro [14]. Furthermore, all of RGK proteins
have been shown to interact with 14-3-3 proteins, a family of regulatory proteins which
contain conserved domains analogous to the Src homology 2 (SH2) and phospho-tyrosine
binding (PTB) domains and are capable of binding to serine/threonine-phosphorylated
residues from a variety of intracellular signaling proteins [43]. RGK/14-3-3 association
requires RGK proteins to be phosphorylated specifically on N- and C- terminal serines
[44-48] and this binding appears to provide a unique way to modulate the subcellular
localization of RGK proteins [44, 46, 47, 49, 50]. For example, RGK proteins are found
at submembranous/cytoplasmic regions and in the nucleus when overexpressed in COS
cells, overexpression of 14-3-3 proteins leads to the exclusion of RGK proteins from the
nucleus [44, 46, 47]. More interestingly, 14-3-3 overexpression can result in efficient
translocation of camodulin binding null mutants of RGK proteins from the nucleus to the
cytosol [44, 46, 47]. In addition, phosphorylation of Ser261 and Ser289 in the Gem Cterminus has been suggested to play a role in Gem-mediated cytoskeletal rearrangements
[45], although Ser261 phosphorylation is not required for either 14-3-3 or calmodulin
binding [45]. On the other hand, these same residues phosphorylation do not contribute to
Gem-mediated inhibition of Ca2+ channel function [45], indicating that the two known
functions of Gem, and possibly other RGKs, are independently regulated. In summary, as
the primary post-translational modification, phosphorylation of RGK proteins provides
efficient ways to regulate the subcellular localization as well as the interactions with
regulatory proteins; thereby enabling the fulfillment of the functional roles of RGK
proteins.
1.4.3 Subcellular localization
Although a large fraction of RGK proteins have been shown to be enriched at the
plasma membrane, they do not undergo canonical lipid modifications as observed for
most Ras family members [51]. Individual RGK proteins have been shown to be
localized to the cytosol, nucleus, and colocalized with both the actin and microtubule
networks [4, 5, 20, 44, 46, 47, 49-57]. The carboxyl terminus of RGK proteins is well

8

conserved (Figure 1.1) and has been shown to play an important role in directing the
subcellular distribution [4, 5, 56] and contributing to protein-protein interactions [48, 56,
58]. More importantly, the conserved C-terminus also plays a crucial role in regulating
both Ca2+ channel activity [52, 56, 58] and cytoskeletal reorganization [44-47, 49, 50, 55]
for the RGK proteins. This region contains a cysteine residue within a highly conserved
domain comprising seven amino acids termed as the C-7 motif (Figure 1.1 and [59]).
Despite the potential to serve as a site of prenylation, there is no evidence that this
cysteine residue is modified, and deletion of the C-7 domain does not alter RGK
localization or function [8, 51, 56, 58]. Therefore, RGK appears to be targeted at the
plasma membrane through a mechanism other than classical lipid modification. Recent
work by Heo and colleagues demonstrated that RGK proteins, as well as other Rasrelated GTPases containing multiple polybasic residues in their C-termini, are capable of
being targeted to the plasma membrane through C-terminal domain interactions with
phosphatidylinositol phosphate (PIP) lipids [60] (Figure 1.1). Additional studies will be
necessary to determine whether PIP lipid binding is required for RGK activity and the
recent studies using Rem and Rem2 C-terminal truncation mutants from our lab did
suggest a strong correlation between PIP-lipid interaction, plasma membrane localization,
and Rem/Rem2-dependent Ca2+ channel regulation [56, 61]. In addition to plasma
membrane targeting through the C-terminus, three specific nuclear localization signals,
with one localized at the C-terminus and the other two localized within the G-core
domain have also been reported in all RGK proteins [49, 50]. Recent studies suggest that
nuclear sequestration may play a role in regulating RGK GTPase function, and appears to
be controlled in part through interactions with both calmodulin and 14-3-3 proteins (see
chapter 1.5 and 1.6.6) [44-47, 49, 50].

1.5 RGK regulation of cytoskeletal dynamics: modulation of Rhodependent signaling
One of the primary physiological roles identified for RGK proteins is the regulation
of actin cytoskeleton dynamics and cell morphological differentiation. Rho GTPase and
its downstream effector Rho-Kinase (ROK) have been demonstrated to play a crucial role
in orchestrating the formation of contractile actin-myosin filaments, which promotes the
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assembly of stress fibers and focal adhesions in fibroblasts and epithelial cells, or induces
cell rounding and neurite retraction in neuroblastoma cells [62-65]. Gem overexpression
has been shown to antagonize Rho kinase induced neurite retraction and cause
morphological differentiation in N1E-115 and SH-SY5Y neuroblastoma cells [28, 45,
53]. In epithelial or fibroblastic cells, Gem or Rad overexpression results in stress fiber
disassembly and focal adhesion dissolution [45, 53]. Consistent with these data,
overexpression of Rad by either transient or stable transfection in vascular smooth muscle
cells inhibits the formation of focal adhesions and stress fibers by antagonizing Rho/ROK
signaling pathway [23]. Gem and Rad have been shown to oppose Rho pathway signaling
through direct interaction with Rho kinase β or α [53]. Gem has been demonstrated to
inhibit ROKβ-mediated phosphorylation of myosin light chain (MLC) and the myosinbinding subunit (MBS) of myosin light chain phosphatase (Figure 1.2) [53], resulting in
the disruption in the normal assembly of stress fibers and focal adhesions. Furthermore,
overexpression of Ges, the human orthologue of Rem in several different types of
endothelial cells has been shown to promote cell sprouting, namely, the morphological
change from round/oval to elongated or dendritic-like morphology [66] and to inhibit the
assembly of focal adhesions and stress fibers in human umbilical cord artery endothelial
cells [66].
Intriguingly, a yeast-two hybrid study has identified a novel Gem-interacting protein
named Gmip [67], which interacts with Gem through its N-terminal half and contains a
Rho GTPase activating protein (RhoGAP) domain at its C-terminus. Gmip enhances the
intrinsic GTPses activity of RhoA in vitro and in vivo [67]. Furthermore, the active form
of Gem was reported to interact with activated Ezrin at the plasma membranecytoskeleton interface [68]. Ezrin association also appears to be required for Gemmediated cell elongation and cytoskeleton reorganization and this process appears to
occur by downregulating the Rho pathway via the participation of RhoGAP Gmip (Figure
1.2) [68]. Although the exact mechanism underlying the Ezrin-dependent and Gmipparticipated inhibition of Rho GTPase pathway is elusive and remained to be fully
clarified, this study provided new insight for the existence of a second pathway by which
RGK regulates Rho-regulated cytoskeleton organization.
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The importance of an intact microtubule network, another key component of
cytoskeleton filaments, has also been shown to be crucial for Gem-mediated cell
elongation in COS cells [54]. The identification of a novel microtubule-associated
protein, kinesin-like protein (KIF9), as a Gem-binding partner in a yeast-two hybrid
screen pointed out the possibility that KIF9 may recruit Gem on microtubules to facilitate
the interaction between Gem and its downstream effector proteins [54]. Another
microtubule-associated protein, tau, has been shown to be able to abolish Gem-induced
elongation of Chinese hamster ovary cells [31], although direct interaction between Gem
and tau was not observed, Gem GTPase mRNA was significantly upregulated in the
brains of tau-deficient mice at eight weeks of age, suggesting that tau may play a role in
Gem-regulated signal transduction pathway [31].
Recently, three specific nuclear localization signals (NLS), which are well
conserved in all RGK proteins, have been shown to contribute to the nuclear localization
of RGK GTPases through interactions with different importin isoforms [69, 70].
Furthermore, two well-known binding partners of RGK proteins, calmodulin and 14-3-3,
have also been shown to regulate RGK nucleocytoplasmic shuttling and more
importantly, to mediate cell shape remodeling in fibroblast and skeletal muscle cell lines
[44, 46, 47, 69, 70]. Overexpression of 14-3-3 has been shown to abrogate RGK-induced
dendrite-like extensions in COS cells [44, 46, 47] through a yet to be defined mechanism.
Mutant RGK proteins which do not bind CaM display a predominant nuclear localization
and lose their ability to induce cell shape changes [44, 46, 47, 69, 70], indicating the
importance of the subcellular localization in RGK-mediated cytoskeleton reorganization.
Moreover, phosphorylation of a couple of serine residues in Gem C-terminus is required
to maintain cytoplasmic localization [69], which may explain why phosphorylation of
these residues is required for Gem-mediated cytoskeleton reorganization [45]. Therefore,
nucleocytoplasmic shuttling of RGK proteins may represent an important modulatory
mechanism in mediating RGK-dependent cell shape remodeling and cytoskeleton
reorganization, and this process seems to be dynamically regulated by ubiquitously
expressed intracellular proteins and the phosphorylation status of the RGK C-terminus.
Whether and how these dynamic processes are correlated with Rho GTPase-mediated
cytoskeleton reorganization remains to be clarified.
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In summary, RGK proteins may mediate cytoskeleton reorganization and cell shape
remodeling by regulating Rho-dependent pathways through two different mechanisms.
Figure 1.2 depicts the proposed mechanisms for Gem. In the first, Gem antagonizes Rhomediated cytoskeleton reorganization through direct association with ROKβ, thereby,
inhibiting the phosphorylation of myosin light chain and myosin phosphatase and
abolishing the formation of myosin–actin filaments [53]. In the second, GTP-bound RGK
proteins interact with the membrane-cytoskeleton linker protein Ezrin in its active state
and direct the Rho-GAP protein Gmip to the plasma membrane. Recruitment of Gmip
down-regulates Rho pathway signaling; inhibiting the formation of stress fibers and focal
adhesions [67, 68]. These two mechanisms could act synergistically or independently to
down-regulate activities of Rho pathways.

1.6 RGK inhibition of voltage-dependent Ca2+ channels
The other major function of RGK proteins is to regulate voltage-dependent Ca2+
channel (VDCCs) activity. Since this dissertation is focused on addressing the molecular
mechanisms underling this regulation, I will first provide background information for the
VDCCs, including their structure, functions, classification, and regulation by kinases
pathways. The proposed mechanisms for RGK-mediated VDCC regulation will be then
discussed in detail.
1.6.1 Introduction of VDCCs
VDCC plays a central role in mediating Ca2+ entry into electrically excitably cells
and it modulates a wide variety of cellular functions including excitation-contraction
coupling in cardiac muscle cells, neurotransmitter releasing and dendritic Ca2+ transients
in neurons, hormone secretion in endocrine cells, and gene expression in many different
cell types (Figure 1.3) [71]. VDCC opens in response to membrane depolarization, a
change in the membrane potential toward the less negative value [71]. Based on their
specific physiological and pharmacological properties, five types of VDCCs have been
identified, including L-, P/Q-, N-, R-, and T-type (Figure 1.3). L-type currents are “long
lasting” currents when Ba2+ is used as the charge carrier [72] and they are activated at
relatively high voltage and characterized by large single channel conductance, slow
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dihydropyridines, phenylalkylamines and benzothiazepines [73]. In contrast, T-type
currents are “transient” currents which activate at much more negative membrane
potentials, inactivate very rapidly, have small single-channel conductance and are
insensitive to Ca2+ antagonist drugs [72]. N-type Ca2+ currents are characterized by their
intermediate voltage-dependence and rate of inactivation in comparison with L-type and
T-type Ca2+ channels [72]. N-type Ca2+ channels are insensitive to L-type Ca2+ channel
blockers but are blocked by the cone snail peptide ω-conotoxin GVIA [74, 75]. In
addition, P/Q type Ca2+ currents are distinguished by their sensitivity to the spider toxin
ω–agatoxin IVA [76, 77]. L-type and T-type Ca2+ channels are expressed in a wide
variety of cell types, however, P/Q-, N- and R-type Ca2+ channels are predominantly
expressed in neurons [71]. VDCCs have also been classified, according to the voltage
dependence of activation, into high voltage activated (HVA) channels, including L-, P/Q, N-, R-type (Figure 1.3) and low voltage activated (LVA) channels, including T-type
channel (Figure 1.3). T-type channel may play important roles in cardiac pacemaker
activity and the oscillatory activity of some thalamic neurons [71].
1.6.2 Structure of VDCCs
VDCCs minimally consist of a pore-forming α1 subunit, an intracellular β subunit,
and a transmembrane complex α2/δ subunit [71] (Figure 1.4). Ca2+ channels purified
from the transverse tubule membranes of skeletal muscle also contain a γ subunit [78].
The α1 subunit is a protein of 190-250 kDa [79] and possesses gating function. The α1
subunit has four homologous domains, each composed of six transmembrane helices
connected by variable intracellular loops, and cytoplasmic domains containing the amino
(N) and carboxyl (C) termini (Figure 1.4). The four α1 domains cluster in the membrane
to form the ion pore and the voltage sensor for the channel, which is primarily formed by
positively charged lysine and arginine residues in the S4 helix of the four homologous
domains. Upon membrane depolarization, S4 segments move outward and rotate in
response to the electric field and this movement triggers a conformational change that
enables the opening of the pore [71]. A membrane associated loop between
transmembrane segments S5 and S6 which lines the pore of the channel, contributes to
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the ion selectivity of the channel [80, 81]. To date, ten different α1 subunit genes have
been cloned, which provide unique functional properties to Ca2+ channels found in
different cell types [71]. Differences in the nature of the α1 subunits largely determine the
different types of Ca2+ currents. Those subunits are divided into three related families
(Cav1, Cav2, and Cav3) based on their structural and functional similarities [82]. The Cav1
family of α1 subunits conducts the L-type Ca2+ current. Cav2.1, Cav2.2, and Cav2.3
subunits mediate the P/Q-type, N-type, and R-type of Ca2+ current, respectively. T-type
Ca2+ currents are conducted by Cav3 channels (Figure 1.3). The accessory β subunit is
localized intracellularly and plays an important role in enhancing peak current amplitude
for the L-type, P/Q-type, N-type, and R-type channels, increasing the number of channels
at the cell surface and regulating channel gating properties [83]. A conserved α1
interaction domain (AID) located between the first and second repeats of the Cavα1
subunit, serves as a high affinity binding site for all Cavβ’s (Figure 1.4). AID:β
association promotes trafficking of the channel complex to the plasma membrane and
results in increased current density [84]. Four different β subunits (β1-β4) have been
identified and they have distinct effects on voltage-dependent and kinetic properties of
channel activation [83]. The α2 subunit is a highly glycosylated extracellular protein that
is attached to the membrane spanning δ subunit by means of disulfide bonds [85, 86]. γ
Subunit is a glycoprotein having four transmembrane segments [87]. So far, four α2/δ
complexes and two γ subunits have been identified. Although coexpression of α2/δ or γ
subunit increases the peak amplitude and affects the activation or inactivation kinetics of
channel complexes [88], they have much smaller functional effects compared with the
effects derived from the coexpression of β subunits [89, 90].
Different types of Ca2+ channels are regulated through distinct intracellular signaling
pathways. Cav1 family of Ca2+ channels are regulated primarily by protein
phosphorylation through second messenger activated kinase pathways [71]. Cav2 family
of Ca2+ channels are regulated primarily by direct association with G proteins, and
SNARE proteins and are also regulated by protein phosphorylation [71]. The regulation
of Cav3 Ca2+ channels is not well understood. Because this dissertation is focused on
understanding RGK-mediated cardiac Cav1.2 channel regulation, only regulation of
Cav1.2 cardiac Ca2+ channels will be discussed further.
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1.6.3 Regulation of Cav1.2 cardiac Ca2+ channels by protein kinase A and C
Ca2+ influx mediated by Cav1.2 L-type Ca2+ channels plays a crucial role in cardiac
excitation-contraction coupling, which is the process that links electrical excitation of the
cardiomyocytes to contraction of the heart [91]. The activation of the L-type Ca2+
channels contributes to the plateau phase of the cardiac action potential. A variety of
cardiovascular diseases, including atrial fibrillation [92, 93], heart failure [94-96] and
ischemic heart disease [97] have been correlated with alterations in the density or
function of L-type Ca2+ channels. In cardiomyocytes, L-type Ca2+ channels are located
primarily at sarcolemmal-sarcoplasmic reticulum (SR) junctions which are in close
proximity to the Ca2+ release channels (or ryanodine receptors; RyRs) [98]. When L-type
Ca2+ channel opens, Ca2+ influx triggers the release of intracellular stores of the Ca2+
from the SR, the combination of Ca2+ influx and efflux from intracellular stores leads to
the rapid increase of the free intracellular Ca2+ concentration, enabling Ca2+ to bind to the
myofilament protein troponin C, which results in the activation of the myofilaments and
the ensuing heart contraction [91]. Cardiac L-type Ca2+ channels are regulated by a
variety of neurotransmitters, hormones, and cytokines. β-Adrenergic modulation in
cardiac muscle is the most thoroughly studied and a well-established model of regulation.
β-Adrenergic stimulation remarkably enhances Ca2+ current and contributes to the
increased cardiac contractility, heart rate, and amplitude of the cardiac action potentials
[99, 100]. β-Adrenergic receptors are members of the heterotrimeric G protein-coupled
receptors (GPCRs). β-Adrenergic receptor stimulation activates a GTP-binding protein
Gs, which stimulates adenylyl cyclase (AC). An increase in AC activity leads to increased
intracellular cAMP, which in turn binds to the regulatory subunits of cAMP-dependent
protein kinase (PKA). Full length Cav1.2 subunit is phosphorylated on a single serine
residue (ser1928) in the distal C-terminus by PKA [101]. Because mutation of this serine
residue to alanine abolishes PKA-mediated regulation of Ca2+ channel activity [102], it
has been proposed that ser1928 phosphorylation at least partially contributes to the PKAdependent activation of Ca2+ channel activity.
cAMP-dependent protein kinases are usually found to be anchored to specific
subcellular compartments where they are in close proximity to their specific kinase
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substrates by A kinase anchoring proteins (AKAPs) [103, 104]. These proteins consist of
a targeting domain that associates with the regulatory subunit of cAMP-dependent
protein kinase. AKAPs were thought to be an ideal candidate to bring PKA to close
proximity to Ca2+ channel because the regulation of skeletal muscle Ca2+ channel by PKA
occurs in a timescale of 50 ms [71]. Immunoprecipitation studies identified a novel 15
KD AKAP (AKAP-15) associated with skeletal muscle L-type calcium channels [105].
Consistent with this finding, a peptide containing the amino acid sequence of an AKAP
anchoring domain effectively inhibits rapid, voltage-dependent enhancement of skeletal
muscle Ca2+ channel activity in cultured skeletal muscle cells [106] or in HEK cells
expressing those channels [107]. AKAP-15 is expressed in the heart [108, 109] and it
colocalizes with Cav1.2 channels and PKA in the transverse tubules of isolated
ventricular myocytes [110]. It has also been shown that AKAP-15 directly interacts with
the distal C-terminus of the cardiac L-type channels and that this interaction is required
for β-adrenergic regulation of Cav1.2 channels via the PKA signaling pathway in
ventricular myocytes [110]. Single channel studies have been used to elucidate the
mechanism of regulation of cardiac Ca2+ current by cAMP-dependent protein kinase.
While conflicting data have been generated in terms of changes in the number of
functional channels recorded in response to the β-adrenergic agents in rat or frog
myocytes [111-113], β-adrenergic stimulation is proposed to increase the channel
opening probability by shifting the channel gating mode from the null gating mode P0, in
which channels do not open or open very rarely upon depolarization to the P1 and P2
modes, which are characterized by low opening probability and brief opening or much
higher opening probability and longer opening, respectively [71]. While the
phosphorylation of Cav1.2 C-terminus at position 1928 appears essential for the βadrenergic modulation of the Ca2+ current in cardiac muscle, β-subunits of cardiac Ca2+
channels have also been reported to be phosphorylated by PKA in intact hearts treated
with β-adrenergic agonists [114] and the phosphorylation of ser478 and/or ser479 of β2a
subunit has been proposed to play a role in regulation of cardiac Ca2+ channels activity
[115].
PKC also plays an important role in the regulation of cardiac L-type Ca2+ channels.
Multiple Gq protein-coupled receptors, such as endothelin, α1-adrenergic, and angiotensin
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II receptors initiate the signaling pathways resulting to the activation of PKC [116].
Activation of PKC in cardiomyocytes has been shown to produce complicated effects on
Ca2+ current and heart contractility. A transient increase followed by a sustained decrease
in Ca2+ current has been reported upon PKC activation [117-119]. Different responses
between Cav1.2 channels cloned from heart and brain upon PKC activation have been
observed, which has led to the hypothesis that structural differences in the N-termini of
these channels may contribute to these distinct regulatory consequences. Additional
mutagenesis studies have indicated that threonine 27 and threonine 31 of the cardiac
isoform must be phosphorylated by PKC to inhibit Ca2+ channel activity [120].
Conflicting results have also been reported in studies focused on understanding the
modulation of Ca2+ current by PKC. The distinct effects may be due to differences in
experimental conditions, species, PKC isoforms, and methods used to study Ca2+ channel
modulation [121]. Clearly, the effect of PKC activation on cardiac Ca2+ channels
modulation awaits further investigation.
1.6.4 Ca2+ channel self-regulation: voltage-dependent inactivation (VDI) and
calcium-dependent inactivation (CDI)
As a key mediator of Ca2+ influx into cardiac myocytes, the opening and closing of
VDCCs need to be tightly regulated. In cardiomyocytes, several pumps and exchange
proteins function together to remove Ca2+ ions from the cytoplasm to restore the basal
level of Ca2+ concentration needed before relaxation of cardiac muscle can occur. These
transporters and exchange proteins include SR Ca2+-ATPase, sarcolemmal Na+/Ca2+
exchanger, sarcolemmal Ca2+-ATPase and the mitochondrial Ca2+ uniporter [91]. In
addition to these pathways, two distinct mechanisms named after their primary trigger,
either voltage- or Ca2+-dependent inactivation, also play essential roles in fine-tuning the
intracellular Ca2+ levels to prevent toxic Ca2+ overload. Membrane depolarization not
only triggers the opening of Ca2+ channels, but also promotes the closure of these
channels, with voltage-dependent inactivation (VDI) being the process of channel
inactivation generated by membrane depolarization. Ca2+-dependent inactivation (CDI) is
characterized by the ability of entering Ca2+ to accelerate channel closing during a
sustained depolarization.
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As described above, inactivation of Cav1.2 channels is mediated by both voltage and
Ca2+ [122]. VDI can be recorded by using extracellular Ba2+, a cation that can not bind
calmodulin. Thus, CDI can be experimentally separated from VDI simply by replacing
Ba2+ by Ca2+ [123]. L-type CDI is characterized by a decrease in the mean channel
opening time during sustained depolarization when Ca2+ is used as the charge carrier and
single channel recordings indicated that the Ca2+ influx through a single channel is
sufficient to induce CDI [124].
Due to the observations that strong Ca2+ chelators such as BAPTA fail to inhibit
CDI of L-type Ca2+ channels [125], the Ca2+ sensor for CDI is assumed to be located
close to the inner mouth of the channels. The proximal portion of the C-terminal tail of
Cav1.2 channels contains a short sequence which is homologous to a Ca2+-binding EF
hands. This EF hand motif was originally thought to be the Ca2+-binding site and this
binding process was thought to trigger CDI [126]. However, subsequent studies indicated
that this EF-hand is not an operational Ca2+-binding site [127] and instead calmodulin
was acknowledged to be the main Ca2+-sensor mediating CDI [128, 129]. Calmodulin
(CaM) is a ubiquitously expressed Ca2+ binding protein that is comprised of four FE-hand
motifs. The two lobes at the C-terminus of CaM exhibit high affinity for Ca2+ (Kd
approximately 0.1 μM) and the other two lobes at the N-terminus show relatively low
affinity for Ca2+ (Kd approximately 1 μM) [130]. One important question concerning
Ca2+/CaM-mediated Ca2+ channel inactivation is how CaM may be tethered to the Ca2+
channels. There are a couple of lines of evidence indicating that CaM is constitutively
tethered to the channel complex, even before any Ca2+ influx occurs. First, CaM tethering
can explain how the development of CDI occurs within milliseconds after the opening of
L-type Ca2+ channels [131]. Secondly, it can help explain the observation that
overexpression of a Ca2+ insensitive CaM mutant (CaM1234, a mutant that fails to bind
calcium to any lobe) disrupts CDI in a “dominant-negative manner”. It is hypothesized
that binding of the mutant to the tethering site precludes binding of wild type CaM [128,
129, 132]. The finding that a Ca2+-insensitive CaM mutant which is unable to bind Ca2+
at three of its four EF hands also functions as a dominant-negative to block CDI suggests
that Ca2+ -free CaM (ApoCaM) can bind to L-type Ca2+ channels [129]. Furthermore,
CaM with Ca2+ bound at only one of the lobes can also bind to VDCCs and regulate their
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function [133-136]. In fact, CDI of Cav1.2 channels depends on Ca2+-binding to the Clobe of CaM [137]. The ability of channels to bind multiple forms of CaM in which Ca2+
binds different lobes of the protein increases the flexibility of channel regulation in
response to different channel functional states [138]. An important unanswered question
is the exact location of the docking site(s) of ApoCaM or Ca2+/CaM on Cav1.2 channels.
It has been established that the C-terminal tail of the Cavα1 subunit is the primary docking
site for CaM [128, 129]. In the proximal Cav1.2 C-terminus, three conserved regions
designated as A, CB, and IQ domains, all have been implicated in ApoCaM binding,
although the exact amino acids involved in ApoCaM binding remains controversial [138].
Pitt et al. [137] proposed that ApoCaM is anchored close to the A and CB motifs in
Cav1.2 channels. While this finding was been supported by additional studies [139],
Erickson et al. [140] also reported that mutations in the IQ region abolished ApoCaM
binding using fluorescence resonance energy transfer methods, suggesting that the IQ
motif may also play a role in ApoCaM binding. Furthermore, Tang et al. [141] reported
an interaction between ApoCaM and a synthetic IQ peptide. Moreover, A, CB and IQ
motifs have all been implicated in the tethering of Ca2+-CaM [137, 142-144]. Although
the exact binding sites for ApoCaM and Ca2+-CaM on the Cav1.2 C-terminus is
controversial, and appear to dependent in part on the functional status of the channel
[138], there is general agreement that Ca2+ binding to CaM elicits a major conformational
change in the Cav1.2 C-terminus which initiates CDI [139, 145]. In one of these models,
at resting Ca2+ levels, CaM is proposed to occupy sequences A and CB, with its N-lobe
associated with domain A, whereas peptide CB is localized between the N- and C-lobes
of CaM. Upon membrane depolarization Ca2+ ions flux into the cell and bind to the Clobe of CaM which enables a direct interaction between the IQ domain of the α1 subunit
and the C-lobe of CaM. This process is proposed to trigger the development of CDI and
rapid channel inactivation [137]. A recent study by Pitt and colleagues suggests that Ca2+
-bound CaM elicits a conformational change within the Cav1.2 C-terminus which
promotes its binding to the α1C I-II intracellular linker, resulting in channel inactivation
[145]. Indeed, mutation of an isoleucine resdiue to a glutamate within the IQ domain (IQ
to EQ) dramatically disrupts CaM binding and abolishes CDI [129]. Mutations of other
residues in the IQ domain which disrupt IQ:CaM association also prevents CDI [131]. It
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has also been proposed that both CDI and Ca2+ signal transduction depend on the
mobility of the Cavα1 C-tail [139]. In this model, ApoCaM binds to a preIQ domain in
resting channels, and upon channel opening, a Ca2+-dependent switch of CaM from the
preIQ domain to the IQ domain removes CaM from the inner mouth of the pore and thus
facilitates the constriction of the pore by promoting the movement of S6 segments toward
the pore [139].
CaM has also been shown to interact with N-terminus of L-type Ca2+ channels in a
Ca2+-dependent manner [125, 146] and this association has also been shown to contribute
to the generation of CDI [125]. Although it has not been well established, Ca2+/CaM has
been proposed to bridge N- and C-terminus of L-type Ca2+ channels to induce CDI [125].
Ca2+/CaM-mediated CDI represents an essential auto-regulatory process in L-type
Ca2+ channel activity and this regulation requires participation of the C-terminus of Cavα1
subunit, which has been shown to play a role in Rem-mediated L-type Ca2+ channel
regulation [57]. Since my project focuses on addressing the interaction between Rem and
the C-terminus of Cav1.2 subunit and its role in Rem-mediated channel regulation, an
important question is whether Ca2+/CaM competes with Rem for Cav1.2 C-terminus
binding and whether Rem:Cav1.2 C-terminus association alters the kinetics of CDI.
Those questions will be addressed in chapter 4.
1.6.5 Other important functions of the Cav1.2 C-terminus
In addition to its well-established role in CDI, the IQ domain also plays an important
role in Ca2+-dependent facilitation (CDF) [129], a process by which increased basal Ca2+
or repeated transient depolarization results in enhanced channel opening [147]. In
addition, Ca2+/Calmodulin-dependent protein kinase II (CaMKII), a multifunctional
Ser/Thr protein kinase, has been demonstrated to bind to Cav1.2 C-terminus in a region
that includes the CB/IQ domain to support CDF during repetitive depolarization [148].
The distal Cav1.2 C-terminus also contains inhibitory elements [149-151]. Removal of up
to 70% of the C-terminus has been reported to increase current density by enhancing
opening probability of the channel [151]. Interestingly, a recent study has demonstrated
that the Cav1.2 C-terminal fragment which contains residues after CB/IQ domain to the
end of C-tail can regulate gene transcription by translocating to the nucleus [152]. This
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provides the first evidence that the Cav1.2 C-terminus has a dual function contributing to
channel regulation and as a transcription factor.
1.6.6 Regulation of VDCCs function by RGK proteins
In 2001, Beguin and colleagues first identified an interaction between the Gem
GTPase and the β subunit of the VDCCs in a yeast two-hybrid study and they also
reported that overexpression of Gem potently inhibits high-voltage-activated calcium
channels activity [55]. In the same study, they proposed that Gem interferes with CaVα1
trafficking to the plasma membrane by sequestrating CaVβ from CaVα1 [55] (Figure
1.5A), which is required for the formation of the functional channel complex at the cell
surface [153]. Thus, Gem-mediated CaVβ sequestration would lead to decreased channel
activity upon overexpression due to the retention of the newly synthesized CaVα1 subunits
in an intracellular compartment [55]. Recently, all members of the RGK family have
been shown to dramatically inhibit high-voltage-activated calcium channel activity upon
overexpression either in endogenous or heterologous expression systems, including L[11, 25, 55-58, 154-156], P/Q- [55], and N- [52, 55], but importantly not T-type channels
which do not require accessory β-subunits for ionic current expression [58, 71].
Furthermore, overexpression of RGK proteins has been shown to inhibit Ca2+-dependent
exocytosis by affecting the activity of L-type VDCCs. Examples include inhibition of
transfected human growth hormone secretion in PC12 and C-peptide secretion in MIN6
cells by Gem [55, 157] , and inhibition of insulin secretion in Min6 cells by Rem2 [25].
Recent studies in Xenopus oocytes demonstrated that the extent of calcium channel
inhibition may depend on the amount of RGK expressed in a specific cell [156]. While
CaVβ binding has been acknowledged as an important component for RGK-mediated
calcium channel regulation [55, 57, 58, 155, 156, 158], the mechanism(s) underling
RGK-mediated channel regulation remain poorly understood. Subsequent work using
immunofluorescence analysis demonstrated that Rad, Rem and Rem2 can all inhibit the
trafficking of epitope-taged CaVα1 to the cell surface [20, 44, 46]. As two common
binding partners for RGK proteins, the importance of CaM or 14-3-3 binding in RGKmediated calcium channel regulation has also been examined. The fact that RGK mutants
which fail to bind 14-3-3 are still capable of inhibiting calcium channel function [44, 46,
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47], indicates that 14-3-3 binding is not required for RGK-mediated channel inhibition.
However, CaM binding appears critical for Gem and Rad [44, 47], but not for Rem and
Rem2-mediated channel inhibition [44, 46, 159]. While the reason for this discrepancy
are not clear, Beguin and colleagues reported that Rem and Rad mutants deficient for
CaM binding predominantly localized in the nucleus along with their associated CaVβ
subunit, suggesting that RGK:CaVβ sequestration within the nucleus might provide a
second mode for regulating α1 trafficking [44, 46, 47, 49, 50].
The effect of RGK overexpression on channel gating current amplitude has also
been investigated. Gating current for L-type Ca2+ channels is induced by the movement
of the voltage sensors located in the S4 segments of the four homologous transmembrane
domains of Cavα1 subunit prior to the channel opening. It provides a way to measure the
number of functional channels with movable voltage sensors in the plasma membrane
[71]. Adenovirus-mediated Gem overexpression in guinea pig ventricular cardiomyocytes
leads to reduced gating currents, which is consistent with a loss of functional channel
complexes at the plasma membrane and supports the trafficking mechanism of RGK
function [160]. Rem overexpression has also been shown to inhibit skeletal muscle EC
coupling and reduce skeletal muscle charge movement, suggesting decreased number of
“functional” L-type Ca2+ channels in the plasma membrane after Rem overexpression
[161]. However, those studies could not determine whether this was

caused by a

decrease in channel number at the plasma membrane or if RGK proteins were capable of
locking channel complexes in a nongating state [161]. In contrast to the reported
reduction in gating current in ventricular myocytes or skeletal muscle cells upon
overexpression of RGK proteins, a recent study using heterologous expressed L-type
Ca2+ channels in HEK293 cells also indicated that acute translocation of Rem from the
cytosol to the plasma membrane can inhibit L-type Ca2+ current amplitude rapidly
without reducing gating charge movement [162]. Moreover, the ability of RGK
expression to alter Ca2+ channel trafficking to date has only been directly demonstrated
for L-type channels in heterologous expression systems [20, 44, 46, 47, 55]. Indeed,
studies using endogenously expressed channels suggest that inhibition of CaVα1
trafficking is not the primary reason for the dramatic decrease in Ca2+ ionic current. For
example, using surface-biotinylation analysis, our laboratory has reported that cell
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surface expressed CaVα1 subunit is not reduced in pancreatic β cells by Rem or Rem2
overexpression at a time when both GTPases result in a complete block of Ca2+ channel
activity [25, 155]. Using another approach, similar finding was reported for Rem2mediated N-type calcium channels stably expressed in tsA201 cells [52]. In the same
paper, it was demonstrated that blocking protein translation in neurons by cyclohexamide
for 20-29 hours did not generate the channel inhibition seen following RGK expression.
Since overexpression of RGK proteins can dramatically and rapidly inhibit Ca2+ current
and RGK proteins have been proposed to interfere with the synthesis of new Ca2+
channels [163], this study argues that turnover of endogenous preformed channel
complexes is not quick enough to generate Ca2+ current block seen in these experiments.
In addition, these studies suggest that RGK proteins are generating acute channel
blockade by promoting a nonconducting complex with channel subunits at the cell
surface [52].
In the trafficking model, an important property for RGK proteins is their ability to
disrupt CaVα:CaVβ association [55, 157]. All CaVβ subunits contain well conserved SH3like and GK-like domains which are connected by three other variable regions [84]. The
primary interaction between CaVα:CaVβ involves the participation of the GK domain
found within all CaVβ subunits and a conserved domain named the AID domain located
in the I-II loop of CaVα1 subunit [84, 164, 165]. Deletion mapping studies have located
the Rem [155] and Rem2 [61] binding domain to a region within the GK domain of CaVβ
subunits. However, CaVβ mutants were identified which had lost the ability to bind CaVα
but retained the ability to bind Rem, suggesting that the AID and Rem association sites
on CaVβ are structurally distinct [155]. More importantly, RGK proteins can not inhibit
the association of CaVβ with AID using both in vitro and in vivo association assays [61,
155], which is perhaps not surprising when you consider that the affinity of RGK proteins
for CaVβ is much lower than the affinity of CaVβ for AID domain [155]. As a matter of
fact, recent studies suggest that CaVβ plays a scaffolding role, simultaneously associating
with RGK and CaVα1 to form a trimeric RGK-CaVβ-CaVα1 regulatory complex [20, 155].
Formation of this complex might inhibit channel function at the plasma membrane,
without disrupting CaVα1-CaVβ association or inhibiting CaVα1 expression at the plasma
membrane (Figure 1.5B). However, it is also possible that a similar RGK-CaVβ-CaVα1
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regulatory complex might form in the endoplasmic reticulum and sequester CaVα1 in this
organelle, serving to reconcile the apparent contradictions in the two regulatory models
(Figure 1.5A).
Since RGK proteins are bona fide GTPases, an important question is whether
VDCC regulation is a GTP-dependent process. It has been reported that in vitro CaVβ
binding requires GTP-bound Gem [55], however, studies from our lab indicate that the in
vitro CaVβ:Rem or CaVβ:Rem2 association does not depend upon the nucleotide-binding
status of Rem [155] or Rem2 [61]. More importantly, channel regulation has been
reported to be nucleotide-independent for Rem2 [52], but GTP binding appears to be
crucial for Rad-mediated channel inhibition [11]. It is possible that different RGK
proteins use different molecular mechanisms to inhibit Ca2+ channel function. Therefore,
the importance of nucleotide binding in individual RGK proteins-mediated channel
modulation awaits further investigations [163].
While the effects of RGK overexpression are well characterized, the physiological
effects of these proteins on calcium channel activity at endogenous levels in native
systems remains poorly characterized. Recent studies using transgenic mice have started
to reveal the physiological roles of RGK proteins. Transgenic mice overexpressing Rad
specifically in skeletal muscle have been shown to be more susceptible to the
development of insulin resistance and glucose intolerance induced by high-fat diet and
exhibit lower plasma triglyceride levels than wild-type littermates [166]. Rad knockout
mice have also been generated and found to be more susceptible to cardiac hypertrophy
and to display increased CaMKII activity when compared to wild-type littermates [10].
More interestingly, the same study also reported that levels of Rad mRNA and protein
were decreased significantly in human failing hearts compared with normal hearts [10]
and Rad expression was decreased significantly in cardiac hypertrophy, suggesting Rad
plays an important role in maintaining normal cardiac function. However, whether
endogenous L-type calcium channel function is altered in the cardiomyocytes from Rad
knockout animals was not investigated. To that end, Yada and colleagues has generated
transgenic mice which overexpress a mutant form of Rad (RadS105N) [11]. S105 in Rad
corresponds to the S17 in H-Ras and overexpression of H-RasS17N enables the
sequestration of GEFs available in the cell and disrupts the GTP-loading and activation of
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endogenous H-Ras [167]. Although biochemical analysis has yet to be performed for
RadS105N, this mutation is postulated to function in a dominant-negative manner by
inhibiting the activity of both endogenous Rad, and perhaps all RGK GTPases by
sequestering putative RGK GEFs [167]. This mutant was found incapable of binding
CaVβ subunits or inhibiting L-type calcium channel activity [11]. Adenovirus-mediated
transduction of the mutant into primary cardiomyoctytes resulted in both increased
current density and prolonged action potential [11], suggesting that RadS105N may
interfere with the normal functioning of wild-type RGK proteins and thus modulate Ca2+
channel activity. ECG recordings from transgenic mice overexpressing RadS105N
demonstrated a longer QT interval and showed an increased propensity for arrhythmia
under both resting and stimulated conditions [11]. To date, this study provides the most
compelling evidence to suggest that RGK proteins are endogenous regulators of VDCCs.
Recently, Murata and colleagues used gene therapy to deliver the Gem GTPase into
porcine heart and showed that it was effective in the reduction of heart rate during atrial
fibrillation, a frequently encountered sustained arrhythmia [160]. Thus, manipulation of
RGK activity might provide a novel therapeutic approach to the treatment of
cardiovascular disease.
Lastly, recent studies also indicated that the conserved C-terminus of RGK proteins
plays important role in regulating VDCCs function [52, 56, 58, 162], primarily by
directing RGK proteins to the plasma membrane (Figure 1.5B). Truncation of the Rem or
Rem2 C-terminus disrupts plasma membrane localization and abolishes VDCC
regulation, but interestingly, does not eliminate CaVβ binding [52, 56, 162]. This has led
to the suggestion that CaVβ binding alone is not sufficient to generate channel inhibition.
However, addition of the C-terminal membrane anchoring domains from K-Ras4B or HRas to the C-terminus of Rem [56, 162] or Rem2 [52] truncation mutants allows for the
recovery of calcium channel inhibition; presumably by restoring the plasma localization,
indicating that the plasma membrane localization is essential for RGK-mediated calcium
channel regulation. This suggests that RGK proteins are likely forming a complex with
the membrane-localized Ca2+ channel subunits to inhibit channel function. Therefore, in
addition to CaVβ binding, the plasma membrane localization of RGK proteins appears to
be another essential determinant in the generation of channel inhibition. Therefore, the
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ability of RGK proteins to modulate Ca2+ channel function may be regulated by altering
their subcellular localizations. In fact, the subcellular localization of RGK proteins has
shown to be regulated by post-translational modifications or interactions with a variety of
binding partners through the RGK C-terminus, including PIP lipids [56, 60, 61],
calmodulin [44, 46, 47, 49, 50] or 14-3-3 [44, 46, 47, 49, 50], etc. For instance, RGK Cterminus

has

been

shown

to

undergo

a

series

of

complex

phosphorylation/dephosphorylation regulation [14, 44-48], which alters the subcellular
localization of these proteins. Furthermore, the RGK C-terminus may target those
proteins to the plasma membrane by interacting with the negatively charged PIP lipids
[56, 60, 61] (Figure 1.5B), and this interaction may be subject to regulation. Indeed, 14-33 bound Rem2 loses its ability to bind PIP lipids, and Rem2:PIP binding can be recovered
by disrupting Rem2:14-3-3 association [61]; thus, 14-3-3 binding is likely able to
sequester Rem2 protein from plasma membrane association and this whole process can
be reversibly regulated by phosphorylating or dephosphorylating a pair of serine residues
located at the N- and C- termini of Rem2 [46]. Therefore, RGK:14-3-3 binding may
provide a potential mechanism for regulating RGK localization and thereby modulating
channel function [61].
In summary, RGK proteins function as important regulators for cytoskeletal
reorganization and VDCC function. Regulation of actin dynamics is achieved through
interference of Rho/ROK signaling pathways. Regulation of the VDCC function appears
to involve association with CaVβ subunits and the plasma membrane localization of the
RGK proteins. Although RGK proteins have been shown to inhibit Ca2+ channel function
by forming a complex with channel subunits at the plasma membrane, little is known
about the molecular mechanisms directing formation and the detailed molecular
interactions within this complex. In addition, Rem has been demonstrated to be able to
partially inhibit L-type current elicited from the overexpression of CaVα1 subunit alone in
HEK293 cells [57]. Furthermore, Rem-mediated VDCC regulation has been shown to be
modulated by protein kinase A signaling, presumably through the modulation of
phosphorylation status of Ser1928 residue located at the distal C-terminus of CaVα1
subunit [57], although it remains to be determined whether this is true for other RGK
proteins. These data suggest that the CaVα1 C-terminus also plays a role in Rem-mediated
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channel regulation. While, the interaction between RGK and CaVβ subunits has been
established, the issues of whether RGK proteins interact with the CaVα1 C-terminus has
not understood. Considering the important roles of CaVα1 C-terminus in channel selfregulation, we first proposed that this domain might play an important role in regulating
RGK-mediated Ca2+ channel regulation by interacting with RGK proteins. We will
examine this hypothesis in the following chapters. Importantly, our studies demonstrate
that RGK proteins directly interact with the proximal CaVα1 C-terminus near the CB-IQ
domain (Chapter 3), which is essential in generating CDI by directing Ca2+/CaM binding.
Another important finding is that CaM and Rem appear to compete for CB-IQ domain
binding and that Rem overexpression alters the kinetics of CDI (Chapter 4). Therefore,
instead of functioning as absolute Ca2+ channel blockers, RGK proteins may serve as
endogenous regulators for calcium-dependent channel inactivation in normal physiology.
This intriguing finding will be addressed in detail in chapter 4.
Dr. Robert N. Correll from our lab generated Figure 1.1 (used with permission). I
generated Figure 1.2, 1.3, 1.4, and 1.5. Those figures were modified based on the models
published in the indicated references listed at the end of each figure.
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Figure 1.1 RGK proteins interact with a variety of factors to regulate their
localization and functions. Human RGK proteins were aligned using ClustalW and
columns are scored as “*” (residues identical among aligned sequences), “:” (conserved
substitutions among aligned sequences), or “.” (semi-conserved substitutions among the
aligned sequences). The putative positions of CaVβ accessory channel subunit,
calmodulin (CaM), and PIP lipid binding regions are indicated. Residues highlighted in
green are known to reduce or eliminate CaM binding, while those highlighted in teal
(basic residues) and orange (hydrophobic residues) are proposed to be involved in PIP
lipid binding. Residues highlighted in red are phosphorylation sites that have been
directly confirmed through experimentation with the exception of S18/S290 in mouse
Rem (and corresponding residues in other RGK proteins) that are thought to be
phosphorylated based on their roles in 14-3-3 association.
(From Correll RN, Pang C, Niedowicz DM, Finlin BS, Andres DA. Cell Signal
2008;20(2):292-300. Used with permission, Elsevier )
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Figure 1.2 Proposed mechanisms for Gem-mediated cytoskeleton reorganization.
Two mechanisms have been proposed for Gem-mediated cytoskeleton reorganization. In
the first, Gem interacts with ROKβ, a Rho GTPase effector protein in a nucleotideindependent manner. This interaction inhibits the phosphorylation of myosin light chain
(MLC) and myosin binding subunit (MBS) of the myosin phosphatase, but not LIM
kinase, and abolishes the formation of myosin–actin filaments, which leads to stress fiber
and focal adhesion disassembly. In the second, GTP-bound Gem interacts with activated
membrane-cytoskeleton linker protein Ezrin and directs a Rho-GAP protein Gmip to the
plasma membrane to inhibit the activity of Rho GTPase. These two mechanisms could
act synergistically or independently to down-regulate activities of Rho pathways.
(Modified from Correll RN, Pang C, Niedowicz DM, Finlin BS, Andres DA. Cell Signal
2008;20(2):292-300.)
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Figure 1.3 Classification and functions of voltage-dependent calcium channels
Modified From William A. Catterall, Annu. Rev. Cell Dev. Biol. 2000, 16: 521-55.
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Figure 1.4 Structural organization of voltage-dependent calcium channels (VDCCs)
VDCCs minimally consist of a pore-forming α1 subunit, an intracellular β subunit, and a
transmembrane complex α2/δ subunit. The α1 subunit contains four homologous domains
(I-IV) (not shown) clustering at the plasma membrane to form the ion pore and possesses
gating functions. The β-subunit is involved in trafficking of α1 subunits. The α2 subunit
is a highly glycosylated extracellular protein that is connected to the membrane-spanning
δ-subunit through disulfide bonds.
Modified from Denise Walker and Michel De Waard, Trends in Neurosciences, 1998,
21(4), 148-154.
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Figure 1.5 Potential mechanisms underlie RGK-mediated VDCC regulation. A)
Regulation of VDCC function by chronic inhibition of CaVα1 traffick. Left, newlysynthesized CaVα1 subunits are trapped in the endoplasmic reticulum (ER) because the III loop of CaVα1 has an ER retention signal and association with a CaVβ subunit
facilitates CaVα1 trafficking to the plasma membrane by antagonizing this retention.
Center, CaVβ subunits have been found to associate with both CaVα1 and RGK proteins to
form a complex. This scaffolded complex may interfere with normal channel trafficking.
Right, RGK proteins sequester CaVβ subunits, rendering them unavailable for CaVα1
association. Therefore, newly-synthesized CaVα1 subunits are retained in the ER. B)
Acute regulation of VDCC at the plasma membrane by RGK proteins. RGK proteins are
proposed to inhibit VDCC activity by forming a trimeric complex with CaVβ/CaVα at the
plasma membrane. In this mechanism, anchoring of polybasic RGK C-terminus to the
plasma membrane by interaction with negatively charged PIP lipids is necessary to
generate channel inhibition.
(Modified from Correll RN, Pang C, Niedowicz DM, Finlin BS, Andres DA. Cell Signal
2008;20(2):292-300.)
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Chapter 2. Materials and Experimental Procedures
2.1 Cell culture
TsA201 cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen)
supplemented with 10% fetal bovine serum (Invitrogen) and 10 μg/ml gentamicin
(GIBCO). HIT-T15 cells were maintained in F-12 Kaighn’s medium (GIBCO) containing
10% dialyzed horse serum (Invitrogen), 2.5% fetal bovine serum (Invitrogen) and 10
μg/ml gentamicin (GIBCO). Horse serum was dialyzed against 0.15 M NaCl for three
times prior to the medium preparation.

2.2 Plasmids
Cav1.2 plasmid (provided by Dr. T. Kamp, University of Wisconsin) is identical to the
originally cloned full-length rabbit cardiac Cav1.2 subunit [168] except for alternative
splicing in domain IV S3 [169]. Rat Cavβ2a plasmid (provided by Dr. E. Perez-Reyes,
University of Virginia) [170] contains two cysteines residues at the N-terminus which
undergo palmitoylation and contribute to the plasma membrane localization of the protein
[83]. GFP-Cav1.2 was kindly provided by K. Beam (University of Colorado Health and
Sciences Center, Aurora, CO). Full-length CCT-Cav1.2 (1507-2171) (CCT-FL) was
generated by PCR using GFP-Cav1.2 as the template and the product was subcloned to
EcoRI/XhoI digested pCDNA3.1+zeo3xHAa [171]. The full-length Cav3.2 CCT, Cav3.2(1861-2353) (Cav3.2-CCT), was generated by PCR using pCDNA3-Cav3.2 as the
template [172] and the product was subcloned to the EcoRI/XhoI sites of
pCDNA3.1+zeo3xHAa. The truncation mutant plasmids, pCDNA3.1+zeo3xHAa-Cav1.2
(1507-1905), PCDNA3.1+zeo3xHAa-Cav1.2 (1507-1773), and pCDNA3.1+zeo3xHAaCav1.2 (1507-1669) were generated by introducing stop codons at amino acid residue
1906, 1774, and 1670, respectively using the Quick change site-directed mutagenesis kit
(Stratagene, La Jolla, CA). All other CCT truncation mutants were generated by PCR
using GFP-Cav1.2 as the template and subcloned into the pCDNA3.1+zeo3xHAa vector.
3xHA-tagged Rem-(1-265)-KCAAX and 3xHA-tagged Rem-(1-265)-HCAAX were
generated by ligation of oligonucleotide corresponding to the C-terminus of human K-
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Ras4B (171-188) or mouse H-Ras (171-189) to the C-terminus of pCDNA3.1+zeo
3xHA-Rem-(1-265) using Xbal/Apal sites [56]. 3xFlag-tagged Rem-(1-265)-KCAAX
and 3xFlag-tagged Rem-(1-265)-HCAAX were generated by PCR and subcloned to the
HindIII/KpnI sites of p3xFlag-CMV-10. 3xHA-tagged Rem-(1-265)-HSAAX, 3xFlagtagged Rem-(1-265)-HSAAX, Cav1.2-(1-1905), and 3xHA-tagged Cav1.2-(19062171)S1928A

were generated using the Quick change site-directed mutagenesis kit

(Stratagene). Mammalian expression vectors (p3xFlag-CMV-10) for Rem, Rad, and
Rem2 bearing an N-terminal 3xFlag tag were generated by PCR. Full length CaV1.2-CCT
(CCT-FL) and the truncation mutants Cav1.2-(1507-1669) (CCT-PX), Cav1.2-(16721905) (CCT-MD), and Cav1.2-(1906-2171) (CCT-DS) were subcloned into pCite4
(Novagen) for production of in vitro translated proteins. PKH3-mCaM was kindly
provided by Dr. Dan Noonan from Department of Molecular and Cellular Biochemistry
at University of Kentucky. All site-directed mutations and PCR reaction products were
verified by DNA sequence analysis.

2.3 Calcium phosphate transfection
HBS (2×): Add the following to 900 ml of deionized water: 10 g of tissue culture-tested
HEPES and 16 g of NaCl. Adjust to pH 7.10 ± 0.05 with 1 M NaOH, adjust the volume
to 1 l, and sterilize by filtration. The correct pH is critical for good DNA precipitation.
Phosphate (50×): Combine 70 mM Na2HPO4 with 70 mM NaH2PO4 (1:1) and sterilize by
autoclaving.
Calcium chloride: 2 M CaCl2 , and sterilize by filtration.
Plasmid DNA: Plasmid DNA can be prepared by the standard alkaline lysis procedure
and purified by CsCl density gradients or by using a variety of commercial ion-exchange
column methods (BioRad Maxiprep kit has been used to prepare the majority of plasmids
used in this dissertation). DNA purity is a crucial factor in maintaining high transfection
efficiency.
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TsA201 cells were transfected with high efficiency by this calcium phosphate method.
The following protocol was used to transfect TsA201 cells cultured on 100-mm dish.
Briefly, 5x106 TsA201 cells were seeded on poly-L-Lysine (0.025 mg/ml in PBS, Sigma)
coated 100-mm cell culture dish 24 h before the transfection. 25 μg of the desired
plasmids for transfection was diluted in sterilized dH2O to a total volume of 550 μl. After
brief vortexing, 75 μl 2M CaCl2 was added. Plasmid mixtures were then mixed again by
vortexing. Separately, an HBS/phosphate mixture was prepared by adding 20 μl 50 x
phosphates to 1 ml of 2xHBS buffer. Plasmid mixtures were then added drop-wise to 625
μl of the HBS/phosphate solution with gentle mixing using a 5 ml sterile polypropylene
round-bottom tube (Vortex Genie set to shake 2). This transfection mixture was then
allowed to incubate for 30 min at room temperature. 1 ml of transfection mixture was
then added drop-wise to the 100-mm dish containing tsA201 cells. These cells were then
incubated with the transfection mixture at 37°C in a humidified 5% CO2 atmosphere for
6h. Cells were then washed once with 1xPBS, and re-fed with standard media.

2.4 Recombinant protein production
Recombinant Rem was expressed as a glutathione S-transferase (GST)-fusion protein. A
Rem PCR product was generated using PCR and subcloned to BamHI/NheI-digested
pGEX-KG [173]. PGEX-KG-Rem was transformed into BL21DE3 cells and grew
overnight, 1 L 2XYT media was inoculated with 10 ml of overnight culture and grown at
37°C to OD600 of 0.6, cells were then induced with 0.5 mM isopropyl-1-thio-β-Dgalactopyranoside and incubated another 4 h at 37°C before harvesting. The cells were
lysed with lysozyme (0.5 mg/ml) in GSTB buffer (10 mM Tris PH7.4, 1 mM Mg2+, 10
μM GDP, 1 mM DTT, and 1 mM PMSF) for 15 min and then subjected to freeze thaw
for 3 times followed by French press for 3 times. GSTC buffer (20 mM Hepes, PH7.6, 1
mM Mg2+, 10 μM GDP, 1 mM DTT, 1 mM PMSF, 20% glycerol and 100 mM KCl) was
added and the cell debris were pelleted at 100,000g for 30 min. Supernatant was then
incubated with glutathione agarose beads (Sigma) for 30 min with end-over-end rotation
at 4 °C, washed 3 times with ice-cold GSTC buffer and GST-Rem was eluted with 25
mM glutathione in GSTC buffer. The eluted protein was then dialyzed against 50 mM
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Tris, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, 1 mM Mg2+ and 10% glycerol and
stored in multiple aliquots at

80 °C.

2.5 In vitro GST pulldown assay
Radiolabeled CCT-FL, CCT-PX, CCT-MD, and CCT-DS were prepared by in vitro
transcription and translation in the presence of [35S] methionine using the Single Tube
Protein System 3 (STP3) kit (Novagen) according to the manufacturer’s instructions.
pCITE-CCT-FL, -CCT-PX, -CCT-MD, and -CCT-DS were used as template for these
reactions. Binding of radiolabeled CCT truncation mutants to Rem were assessed as
follows. Glutathione-Sepharose beads (GE Healthcare) (10 μl) were washed 2 times with
500 µl of EDTA buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 0.05% Tween 20, 1 mM
DTT, 1 mM EDTA), resuspended in 1 ml of EDTA buffer, and GST (10 µg) or GST-Rem
(10 µg) added. The beads were incubated for 5 min with end-over-end rotation at 4 °C,
washed 2 times with ice-cold EDTA buffer (1 ml), and then with either ice-cold EDTA
buffer (1 ml), GDP buffer (1 ml) (50 mM Tris, pH 7.5, 100 mM NaCl, 0.05% Tween 20,
1 mM DTT, 10 mM MgCl2, 20 µM GDP), or GTP buffer (50 mM Tris pH 7.5, 100 mM
NaCl, 0.05% Tween 20, 1 mM DTT, 10 mM MgCl2, 20 µM GTP S) (1 ml) as indicated
to facilitate nucleotide exchange. The resin was resuspended in EDTA, GDP, or GTP
buffer (96 µl total volume) and binding was initiated by the addition of 35S-labeled CCT
full length or truncation mutants (4 µl). Binding reactions were incubated for 3 h at 4 °C
with end-over-end rotation and the resin washed three times with incubation buffer to
remove unbound CCT peptide. GST or GST-Rem was subsequently eluted using two 20µl washes of assay buffer supplemented with 25 mM glutathione. The eluted proteins
were resolved on 10% SDS-PAGE gels, which were dried and exposed to film for 16–72
h to identify bound [35S]-labeled protein. For those experiments in Figure 4.1, binding of
CCT-FL or CCT-PX to Rem was performed in a similar manner except that GDP buffer
containing 2 mM Ca2+ or 5 mM EGTA were used. Purified bovine CaM protein was
kindly provided by Dr. Thomas Vanaman from Department of Molecular and Cellular
Biochemistry at University of Kentucky.

2.6 Co-immunoprecipitation analysis
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3xHA-tagged CCT-FL, CCT-PX, CCT-DS, CCT-MD and either pCDNA3.1+zeo3xHAa
(control), 3xFlag-tagged Rem, Rem2 or Rad GTPases were cotransfected into tsA201
cells by the calcium phosphate method[174]. Forty-eight hours post-transfection, the cells
were washed with PBS, placed into 1 ml of Verseen (GIBCO), harvested, pelleted, and
then suspended in ice-cold immunoprecipitation (IP) buffer [20 mM Tris, pH 7.5/250 mM
NaCl/1% TX-100/0.5 mM DTT/1x protease inhibitor mixture (Calbiochem)/10 mM
MgCl2/10 µM GTPγS]. The cells were lysed by sonication, subjected to centrifugation at
100,000 X g, and 0.5 mg of the supernatant incubated in a 500-µl reaction containing 12.5
µl of packed Protein G Sepharose (Pharmacia) and 5 µg of anti-HA monoclonal antibody
for 3 h with gentle rotation at 4°C. The beads were pelleted and 2.5 µl of the supernatant
saved for analysis. The beads were then washed three times with 1 ml of IP buffer. The
supernatant and bound fractions were resolved on SDS/PAGE, transferred to
nitrocellulose, and subjected to immunoblot analysis using biotinylated-Flag antibody (1
µg/ml) and streptavidin–horseradish peroxidase (Pierce) (1:40,000 dilution). Expression
of 3xFlag-Rem, Rem2 or Rad in whole cell lysates was determined using anti-Flag M2
monoclonal antibody (1 µg/ml) (Sigma) while the expression of 3xHA-tagged CCT-FL
or CCT truncation mutants was analyzed using anti-HA monoclonal antibody (1 µg/ml).
For those experiments shown in Figure 4.2 and Figure 4.3, 3xHA-tagged CCT-PX and
3xFlag-tagged Rem, Rem-(1-265)-KCAAX or Rem-(1-265)-HCAAX were cotransfected
into tsA201 cells by the calcium phosphate method. Coimmunoprecipitation and
immunoblotting analysis was performed in a similar way with the exception that IP
buffer containing 2 mM Ca2+ or 5 mM EGTA was used for the appropriate analysis.

2.7 Confocal imaging
TsA201 cells transfected with green fluorescent protein (GFP)-tagged Rem-(1-265)HCAAX or GFP-tagged Rem-(1-265)-HSAAX were fixed 2 days after transfection. Cells
were washed three times with PBS supplemented with 1 mM CaCl2 and 1 mM MgCl2 and
then fixed in 4% paraformaldehyde on ice for 20 min. Cells were then washed three times
with PBS and mounted on slides with Vectashield. GFP signal was visualized by using a
Leica laser scanning confocal inverted microscope (TCS SP5) equipped with argon laser
to excite the cells at 488 nm and emission long-pass filtering >505 nm. Cells were
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visualized at 64x magnification. Images displayed are representative of the cells
observed.

2.8 β Subunit association assay
3xHA-tagged Rem-(1-265)-HCAAX or 3xHA-tagged Rem-(1-265)-HSAAX was
cotransfected with Flag-CaVβ1b or pCMV-T7/F2 in tsA201 cells using the calcium
phosphate method. Forty-eight hours posttransfection, the cells were washed with PBS,
scraped into 1 ml of Verseen (GIBCO), pelleted, and then suspended in ice-cold
immunoprecipitation (IP) buffer [20 mM Tris, pH 7.5/250 mM NaCl/1% TX-100/0.5 mM
DTT/1× protease inhibitor mixture (Calbiochem)/10 mM MgCl2/10 μM GTPγS]. The
cells were sonicated, subjected to centrifugation at 100,000 X g and 1 mg of the
supernatant incubated in a 500-μl reaction containing 12.5 μl of packed Protein G
Sepharose (Pharmacia) coupled to 4 μg of anti-Flag M2 monoclonal antibody (Sigma) for
3 h with end to end rotation at 4°C. The beads were pelleted and washed three times with
1 ml of IP buffer. The bound proteins were then released by adding 20 μl 2xSDS loading
buffer and boiling for 5 min. The released proteins were resolved on 10% SDS/PAGE,
transferred to nitrocellulose, and subjected to immunoblot analysis. Biotin-HA (1 μg/ml)
was used to detect Rem-(1-265)-HCAAX or Rem-(1-265)-HSAAX in the pelleted
fraction. Biotin-Flag (1 μg/ml) was used to detect Flag-CaVβ1b in the pelleted fraction.
The expression of 3xHA-tagged Rem-(1-265)-HCAAX or 3xHA-tagged Rem-(1-265)HSAAX was analyzed using anti-HA monoclonal antibody (1 µg/ml).

2.9 Calmodulin binding assay
TsA201 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen)
supplemented with 10% fetal bovine serum (Invitrogen) and transfected with the 3xFlag
tagged Rem, Rem-(1-265), Rem-(1-265)-KCAAX, Rem-(1-265)-HCAAX or empty
p3xFlag-CMV10 as the control using the calcium phosphate method[174]. 48 h posttransfection, cells were harvested and lysed in calmodulin immunoprecipitation buffer (50
mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% Nonidet P-40, 1x phosphatase inhibitor
mixture II (Calbiochem), 1x protease inhibitor mixture I (Calbiochem), 1 mM
phenylmethylsulfonyl fluoride), sonicated, and centrifuged at 100,000 x g. Calmodulin38

Sepharose beads (GE Healthcare) were washed twice with immunoprecipitation buffer
and incubated with 1 mg of total lysate in the presence of 2 mM CaCl2 for 2 h with endover-end rotation at 4 °C. Beads were then washed three times in immunoprecipitation
buffer containing 2 mM CaCl2, and proteins were released from the beads with two 20 μl
washes of assay buffer containing 5mM EGTA. The eluted protein were resolved on 10%
SDS-PAGE minigels and transferred to nitrocellulose membranes. Interaction of Rem
proteins with calmodulin was examined by immunoblot with anti-Flag M2 monoclonal
antibody (1 μg/ml) (Sigma).

2.10 Electrophysiology
TsA201 cells were transfected with the indicated plasmids using the calcium phosphate
method, and whole-cell patch clamp experiments were performed [56, 154]. HIT-T15
cells were transiently transfected with the indicated plasmids at 48 h before recording
using lipofectamine reagent (Invitrogen). Transfected cells were identified by GFP
expression. The whole cell configuration of the patch-clamp technique was used to
measure ionic current. Patch pipettes with resistances of 1.5-2 mΩ were pulled from
micropipette glass (VWR Scientific) and fire-polished prior to use. Patch electrodes
contained (in mM) 110 K-gluconate (or 0), 40 CsCl (or 150), 3 EGTA, 1 MgCl2, 5 MgATP, and 5 HEPES, PH 7.36. The bath solution consisted of (in mM) 112.5 CsCl, 30
BaCl2 or CaCl2, 1 MgCl2, 10 tetraethylammonium chloride, 5 glucose, 5 HEPES, PH 7.4.
For both tsA201 and HIT-T15 cells, only those cells with the capacitance less than 15 pF,
series resistance less than 1.2 MOhm were used for data analyis. Approximately 70-80%
of series resistance was compensated with the patch clamp circuitry. In order to eliminate
the contamination of T-type currents elicited from HIT-T15 cells during depolarization,
two protocols were used to record ionic currents derived from any specific cell. In the
first protocol, the I-V relationship was determined by applying 1000 ms voltage pulses at
0.25 Hz to potentials between -90 and 80 mV in 5 mV increments from a holding
potential of -80 mV. For the second protocol, HIT-T15 cells were stimulated at -50 mV
for 200 ms before a series of voltage pulses from -50 mV to 80 mV were applied in 5 mV
increments from a holding potential of -80 mV. This protocol efficiently suppressed
contaminating T-type currents observed in the patch-clamping of HIT-T15 cells, which
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are activated at much more negative potentials than L-type currents [71, 175]. Leak
subtraction and L-type current were obtained by the combination of those two protocols.
Signals were amplified with an Axopatch 200B amplifier and 333 kHz A/D system
(Axon Instruments, Union City, CA). Data was analyzed with Clampfit 9 (Axon
Instruments) and Origin statistical software (OriginLab, Northampton, MA). All
recordings were performed at room temperature (20-22°C). In Figure 3.6, Peak current
values were reported as mean at 15 mV ± SE, and statistical significance was determined
using student’s t-test with p-values of <0.05. In Figure 4.4C and Figure 4.4D, peak
current values were reported as mean at 5 mV ± SE and 20 mV ± SE, respectively; and
statistical significance was determined using Kruskal-Wallis test followed by a post hoc
Dunn’s test with p-values of <0.01 (Graphpad prism5). For the data analysis in Figure
4.6C, the degree of VDI was analyzed using r600, the ratio of the residual current values at
600 ms and at the initial peak. For the data analysis shown in Figure 4.6D, Ca2+ currents
recorded during a typical 1000 ms test pulse applied ranging from 0 mV to +40 mV from
a holding potential of -80 mV at indicated experimental conditions were analyzed using
pclamp10 software and the time constants of inactivation were derived from fitting the
decay phases of the time courses with the following biexponential function equation: i(t)
=A1* exp( t /Taufast) + A2 * exp( t/Tauslow) + C, where t is the time; A1, A2, Taufast, and
Tauslow are the amplitudes and time constants of the fast or slow exponential components;
and C is the fraction of noninactivating current. The fast component of the time constant
of inactivation (taufast) is generated primarily by Ca2+-mediated CaM binding-induced
conformational change to the CCT, the major player in generating CDI [128, 138]. The
value of taufast provides a way to determine the rate of channel inactivation, with smaller
values indicating faster inactivation.

Copyright © Chunyan Pang 2008
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Chapter 3. The Cav1.2 C-terminus Interacts with Rem and
Contributes to Rem-Mediated Calcium Channel Inhibition
3.1 Introduction
High voltage activated (HVA) Ca2+ channels modulate Ca2+ influx upon membrane
depolarization to regulate a wide variety of cellular functions including neurotransmitter
release, hormone secretion or muscle contraction [71]. VDCCs minimally consist of a
pore-forming α1 subunit, an intracellular β subunit, and a transmembrane complex α2/δ
[71], with each of the subunits contributing to the modulation of the kinetics and voltagedependence of channel gating properties [71, 88]. Intracellular domains of the poreforming α1 subunit serve as scaffolds for the targeting and localization of a diverse array
of regulatory molecules. A conserved α1 interaction domain (AID) located between the
first and second repeats of the Cavα1-subunit (loop I-II), serves as a high affinity binding
site for all Cavβ subunits [176] and AID:CaVβ association promotes trafficking of channel
complex to the plasma membrane and results in increased current densities [83, 84, 153].
The Cavα1-subunit C-terminus (CCT), which constitutes approximately 30% of the total
mass of the protein, serves as another major site of modulation [177]. The L-type channel
CCT (residues 1507-2171 for rabbit CaV1.2) serves as the target of various cellular
signaling pathways, including PKA, PKC, CaM, CaMKII, and protein phosphatases PP1
and PP2A [71, 121, 178]. A conserved CB/IQ domain and regions proximal to the CB/IQ
have been reported to contribute to channel auto-regulation, including Ca2+–dependent
inactivation (CDI) through Ca2+-regulated interactions with calmodulin (CaM) [138].
Phosphorylation of the α1 subunit by cAMP-dependent protein kinase (PKA) leads to a
marked enhancement of Ca2+ current in cardiac myocytes [179] and the major
phosphorylation site in the Cav1.2 CCT has been identified as Ser1928 [101].
The expression of exogenous RGK proteins has been shown to potently inhibit highvoltage activated (HVA) Ca2+ channel activity in both heterologous and native systems
[52, 55, 57, 58, 155, 156, 158, 163], mediated in part through interactions of the RGK
GTP-binding core with auxiliary β-subunits and association of the conserved RGK Cterminus with the plasma membrane [56, 163]. Recent studies have also provided
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evidence in support of a role for the Cavα1-CCT in Rem-dependent channel regulation
[57]. In this study, we strengthen these data by identifying a direct interaction between
Rem and the CCT from L-type, but not T-type Ca2+ channels, which are resistant to RGK
regulation [52, 58]. The Rem2 and Rad proteins also associate with the CCT, suggesting
that this domain represents a common binding target for all RGK proteins. Fine mapping
demonstrates that the CB-IQ domain in CaV1.2 plays an essential role in directing RemCCT association, and co-expression of the proximal CCT domain with Rem results in the
partial recovery of ionic current in HIT-T15 cells. Furthermore, while Rem:CaVβ
association alone is not sufficient to generate channel inhibition, Rem:CCT association is
well correlated with both the plasma membrane localization of Rem and more
importantly, channel regulation. These results suggest that CaVα1-CCT association plays
a critical role in Rem-mediated Ca2+ channel regulation.
I generated all of the data shown in Figure 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, and 3.7. Dr.
Brian S. Finlin from our lab kindly provided the purified GST-Rem-(1-265) used for
experiments shown in Figure 3.2 (C). Dr. Robert N. Correll from our lab generated the
GFP-Rem-(1-265)-HRas-CAAX construct and provided the confocal microscopy picture
for this chimeric protein shown in Figure 3.8. I generated the GFP-Rem-(1-265)-HRasSAAX construct and produced the confocal microscopy picture for this protein shown in
Figure 3.8.

3.2 Results
3.2.1 Rem interacts with the L-type, but not T-type CaVα1-CCT
Rem inhibits ICa,L in part through association with auxiliary CaVβ subunits [55, 56,
58, 155, 156], but the contribution of the channel α1-subunit to Rem regulation remains
incompletely characterized [163]. Our recent studies demonstrated that protein kinase A
(PKA) signaling, potentially acting through phosphorylation of the CaV1.2 α-subunit Cterminus (CCT), contributes to Rem-mediated inhibition of CaV1.2 currents [57]. To
explore whether Rem interacts with the CCT, tsA201 cells were transiently co-transfected
with expression vectors encoding 3xFlag-tagged Rem and either 3xHA-empty vector
(control), 3xHA-tagged full-length CCT, or the indicated CCT truncation mutants (Figure
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3.1A, B). HA-CCT or the CCT mutants were then isolated by immunoprecipitation, and
bound Flag-Rem was visualized by immunoblotting. As seen in Figure. 3.1B, Rem was
found to associate with full-length CCT (CCT-FL) (Figure 3.1B, top panel). This binding
appears to involve interactions of Rem with both the proximal (Cav1.2 (1507-1669)
(CCT-PX)) and distal (Cav1.2 (1906-2171) (CCT-DS)) domains, but not with the medial
(Cav1.2 (1672-1905) (CCT-MD)) portion of the CaV1.2-CCT (Figure 3.1B, top panel).
Although not all the CCT fragments were expressed at equivalent levels (Figure 3.1C),
CCT-MD was highly expressed and immunoblotting confirmed that the transfected cells
expressed similar levels of 3xFlag-Rem (Figure 3.1B, lower panel).
RGK proteins are incapable of inhibiting T-type calcium channel function [52, 58],
and the CCT domains of L- and T-type α-subunits display little overall sequence
homology [180]. Therefore, as an added specificity control, we examined the interaction
between Rem and the CaV3.2-CCT. Although the Cav3.2-CCT was expressed at greater
levels than that of Cav1.2-CCT in tsA-201 cells (Figure 3.1D, bottom panel), Rem failed
to interact with Cav3.2-CCT (Figure 3.1D, top panel). Taken together, these studies
indicate that Rem interacts with both the proximal and distal portions of the L-type CCT,
but not with the T-type CCT.
3.2.2 RGK proteins associate directly with the proximal CCT in a nucleotideindependent manner
To further characterize the nature of the Rem-CCT association, we next used

35

S-

labeled, in vitro translated CCT fragments and recombinant glutathione-S-transferase
(GST) fused Rem (GST-Rem) and GST-Rem-(1-265) to explore the Rem-CCT
interaction. The generation of

35

S-labeled CCT-FL or the other three CCT truncation

mutants is shown in Figure 3.2A. GST-Rem directly bound

35

S-labeled CCT-PX, but

failed to associate with CCT-MD. Interestingly, Rem did not interact with CCT-DS
(Figure 3.2B), suggesting that Rem binding with the distal CCT requires additional
cellular binding factors since the interaction was detected when Rem and CCT were cooverexpressed in tsA201 cells (Fig 3.1B). Surprisingly, the conserved RGK C-terminus
appears to contribute to CCT binding, since GST-Rem-(1-265) failed to associate with
either CCT-FL or CCT-PX (Figure 3.2C). In addition, while previous work has suggested
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that RGK-mediated Ca2+ channel regulation may be GTP-dependent [55, 158], CCT
binding to Rem was found to be nucleotide-independent, with both GDP-bound and
GTPγS-bound Rem displaying equivalent in vitro CCT-PX binding (Figure 3.2B).
Since the in vitro binding data indicates that the CCT-PX region is a direct
binding target for Rem within the CCT, to identify the minimum structural sequence in
CCT-PX responsible for Rem association, a series of CCT truncation mutants were
generated (Figure 3.3A) and assessed for their ability to associate with Rem by coimmunoprecipitation. As seen in Figure 3.3B, CCT-(1507-1905), CCT-(1507-1733), and
CCT-(1507-1669) were all capable of interacting with Rem, indicating that residues
beyond the CB-IQ domain do not enhance Rem association. Importantly, while the CCT(1609-1905) truncation mutant which contains the CB-IQ region [129, 138, 145] but
deletes many of the well conserved structural domains from CCT, including the EF hand
[181, 182] and peptide A [137, 145] regions, retained Rem binding, the larger CCT(1672-1905) truncation, which does not contain the CB-IQ domain, failed to demonstrate
any Rem interaction. This was not the result of reduced CCT mutant expression, as all of
the mutants displayed similar levels of expression (Figure 3.3B, bottom panel). Taken
together, this analysis indicates that Rem-CCT association requires the well conserved
CB-IQ domain found in all HVA Ca2+ channels [142].
If CCT association is required for RGK-mediated channel regulation, we reasoned
that CCT binding should be a common property for all RGK proteins. Importantly, when
expressed in tsA201 cells, both Rem2 and Rad GTPases co-immunoprecipitate with the
proximal and distal domains, but not the medial domain, of CCT (Figures 3.4A and
3.4B). Thus, the ability to interact with CCT is a conserved property for RGK family
proteins and suggests that CCT association may contribute to RGK-mediated channel
regulation.
3.2.3 CCT-DS is not required for Rem-mediated L-type ionic current inhibition
The fact that an interaction between CCT-DS and Rem was identified when cooverexpressed in tsA201 cells (Figure 3.1B), but was not seen following the incubation of
purified GST-Rem with radiolabeled in vitro-translated CCT-DS (Figure 3.2B), suggests
that additional intracellular scaffold protein(s) may be required to facilitate this
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association. To further evaluate the importance of CCT-DS in Rem-mediated Ca2+
channel inhibition, tsA201 cells were transiently co-transfected with a Cav1.2 distal Cterminal truncation mutant Cav1.2-(1-1905), β1b and either empty GFP or GFP-Rem.
While control cells expressing Cav1.2-(1-1905)+β1b+GFP displayed >9 pA/pF peak
inward current (Figure 3.5A, filled squares, -9.2 ± 2.3 pA/pF, n=12), coexpression of
GFP-Rem with β1b and Cav1.2-(1-1905) generated a complete block of ionic current
expression (Figure 3.5A, filled circles, -0.1 ± 0.1 pA/pF, n=8). Therefore, CCT-DS is not
essential for Rem-mediated L-type Ca2+-channel inhibition. Previous studies have
suggested that PKA-mediated phosphorylation of Ser1928, located within the CCT-DS
domain, contributes to Rem-mediated inhibition of CaV1.2 currents [57]. To explore the
role of Ser1928 phosphorylation in the association of CCT-DS and Rem, Ser1928 was
substituted to Ala in CCT-DS and the interaction between Rem and CCT-DSser1928A was
examined. As seen in Figure 3.5B, mutation of Ser1928 to Ala did not affect the
association between Rem and CCT-DS, indicating that the phosphorylation of Ser1928 is
not essential for the interaction between Rem and CCT-DS. Immunoblotting confirmed
that the transfected cells expressed similar levels of 3xFlag-Rem, CCT-DS, or CCTDSser1928A (Figure 3.5B). Since CCT-DS does not appear to contribute to Rem-mediated
L-type Ca2+ channel inhibition, we focused the remaining studies on determining the
importance of the Rem:CCT-PX interaction to Rem-mediated Ca2+ channel regulation.
3.2.4 CCT association is important for Rem-mediated channel regulation
To explore the significance of CCT association, we next examined the effect of
CCT-PX and CCT-MD overexpression on Rem-dependent channel regulation in HITT15 cells. HIT-T15 cells were used because those cells express endogenous L-type Ca2+
channels, allowing us to reduce the number of plasmids used for transfection. Because
neither CCT fragment is expected to modulate CaVα1 function, but CCT-PX retains the
ability to bind Rem (Figures 3.1 and 3.2), we reasoned that CCT-PX expression would
not directly modulate Ca2+ channel function but might compete with endogenous L-type
channels for Rem association. HIT-T15 cells transiently co-transfected to express
unfused green fluorescent protein (GFP) and 3xHA-empty vector display >11 pA/pF
peak inward current (Figure 3.6A, filled triangles, -11.3 ± 1.9 pA/pF, n=9). Consistent
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with the notion that the CCT-PX and CCT-MD fragments alone do not modulate Ca2+
channel activity in terms of current density or voltage-dependent channel gating
properties, co-expression of GFP with either HA-tagged CCT-PX or HA-CCT-MD had
no effect on current amplitude or voltage-dependent channel activation (Figure 3.6A, 13.3 ± 1.8 pA/pF for HA-CCT-PX, filled circles, n=6; -13.9 ± 4.5 pA/pF for HA-CCTMD, open squares, n=7) (Figure 3.6B, currents at 15 mV from Figure 3.6A). As we have
described previously [57, 155], co-expression of GFP-Rem with 3xHA empty vector in
HIT-T15 cells results in the absence of detectable ionic current expression (Figure 3.6C,
0.1 ± 0.4 pA/pF, n=9), and importantly, co-expression of HA-CCT-PX, but not HA-CCTMD, was able to partially relieve the Rem blockade of ionic current (Figure 3.6C). In
these experiments, CCT-PX expression resulted in a statistically significant (student’s ttest, p<0.05) increase in peak current amplitude to >2 pA/pF (-2.0 ± 0.9 pA/pF, n=13),
while CCT-MD expression had no effect on Rem-mediated current blockade (0.4 ± 0.5
pA/pF, n=15). Taken together, these data suggest that CCT association plays a critical
role in Rem-mediated channel regulation.
3.2.5 Plasma membrane targeting is essential for Rem:CCT association when cooverexpressed in tsA201 cells
To determine whether the Rem C-terminus is required for CCT association, we next
analyzed the binding of wild-type Rem or Rem-(1-265) to CCT-PX in a coexpression
system. Consistent with our previous results (Figure 3.2C), Rem-(1-265) failed to coimmunoprecipitate HA-CCT-PX, whereas full-length Rem bound the proximal CCT
(Figure 3.7A). We next investigated whether the Rem C-terminus directly contributed to
CCT binding, or if the effect was indirect, perhaps resulting from differential Rem
subcellular localization. For these studies, we made use of two chimeric proteins in which
the C-terminus of K-Ras4B and H-Ras were fused to Rem-(1-265) [56]. We previously
showed that fusion of these CAAX plasma membrane trafficking motifs to Rem-(1-265)
restores both membrane localization and Ca2+ channel regulation [56], and coimmunoprecipitation analysis found that both chimeric proteins were capable of binding
CCT-PX (Figure 3.7A). Therefore, Rem:CCT association is correlated with both Remmediated Ca2+ channel regulation and plasma membrane localization, but does not appear
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to require the conserved Rem C-terminus. To strengthen this correlation, we generated
Rem-(1-265)-HSAAX, a mutant in which the CAAX motif cysteine residue was mutated
to serine, disrupting both prenylation of the H-Ras membrane targeting domain and
membrane trafficking for C/SAAX mutant [183-185]. Confocal microscopy confirmed
that Rem-(1-265)-HSAAX was no longer localized to the plasma membrane (Figure 3.8)
and co-immunoprecipitation studies found that while this mutant fails to associate with
CCT-FL (Figure 3.7B), it retains Cavβ1b subunit binding (Figure 3.7C). In addition, while
GFP-Rem-(1-265)-HCAAX expression resulted in a potent reduction in ionic current
expression (-1.1 ± 0.3 pA/pF, closed triangles, n=8) when co-expressed with Cav1.2+β1b
in tsA201 cells (Figure 3.7D), GFP-Rem-(1-265)-HSAAX did not significantly alter Ca2+
channel function (Figure 3.7D). Whole cell currents elicited in the presence of
Cav1.2+β1b+GFP-Rem-(1-265)-HSAAX (-17.7 ± 3.9 pA/pF, filled squares, n=9) were
indistinguishable from control currents in cells expressing Cav1.2+β1b+GFP (-18.5 ± 4.7
pA/pF, open circles, n=10) (Figure 3.7D). Taken together, these data indicate that,
plasma membrane targeting, but not sequences within the C-terminus, are critical for
Rem:CCT association and further support the notion that CCT binding is necessary for
effective Rem-mediated channel regulation.

3.3 Discussion
All members of RGK GTPases act to inhibit high-voltage activated (HVA) Ca2+
channel function [25, 44, 46, 47, 52, 55, 57, 58, 155, 156, 158, 163]. Interaction between
RGK proteins and accessory CaVβ subunits contributes to RGK-mediated HVA Ca2+
channel function [55, 57, 58, 155, 156, 158], although CaVβ binding alone is not
sufficient for Rem-dependent current blockade [56, 162]. In this chapter, we provide new
insight into the mechanisms of RGK-mediated Ca2+ channel regulation through the
identification of the interaction between the HVA CaVα1-CCT and RGK GTPases and
find that Rem-dependent regulation of HVA Ca2+ channel current appears to require
association with the proximal CCT (Figure 3.6). Thus, in addition to CaVβ association
and plasma membrane localization, these data suggest that interaction with the CB/IQ
region within the proximal CCT is important for RGK-mediated Ca2+ channel inhibition.
Based upon these findings we propose that RGK proteins interact with both Cavβ and
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CCT to promote reorganization of CaVα1 intracellular domains to generate the blockade
of current expression which is the hallmark of RGK-dependent Ca2+ channel regulation
[25, 44, 46, 47, 52, 55, 57, 58, 155, 156, 158, 163].
Rem, Rad, and Rem2 are each capable of interacting with both the proximal
(residues 1507-1669) and the distal (residues 1906-2171) domains of the CaV1.2-CCT
(Figures 3.1, 3.3, 3.4) when co-overexpressed in tsA201 cells. However, in vitro binding
studies using recombinant Rem suggest that the interaction between Rem and CCT-PX is
direct, while that with the CCT-DS domain is indirect and may require an unknown
intracellular anchoring protein(s) (Figure 3.2B). Since the proximal CCT domains of all
HVA Ca2+ channel share greater than 50% amino acid identity, but share less that 10%
identity with the same region within the low voltage activated T-type channels, the
finding that Rem does not associate with the T-type CCT is not surprising (Figure 3.1D).
Interestingly, the proximal CCT contains several functionally important domains
including the conserved EF-hand, A, CB and IQ domains, all of which have established
regulatory roles in L-type Ca2+ channel function. In particular, the A, CB and IQ domains
all have been reported to serve as docking sites for both apocalmodulin (ApoCaM) and
Ca2+-CaM [138]. Although the identity of the exact binding sites for ApoCaM and Ca2+CaM on the CCT remain controversial, and appear to be dependent on the functional
status of the particular channel under study [138], it has been proposed that Ca2+ binding
to CaM elicits a major conformational change in the CCT which initiates calciumdependent inactivation (CDI) [139, 145]. Fine deletion mapping studies indicated that
Rem binding requires the CB-IQ region (Figure 3.3B), suggesting that Rem binding could
alter the interaction of the proximal CCT domain with CaM. It is possible that either
disruption of the normal interactions of CaM with the CCT, or Rem binding-mediated
conformational reorganization of the proximal CCT, could contribute to Rem-dependent
Ca2+ channel blockade. Resolution of how RGK binding might alter CCT domain
structure will require additional studies, but structural analysis of a RGK family memberCaVβ-CaVα-CCT complex may be necessary to fully understand the role of Rem binding
in Ca2+ channel inhibition. The recent solution of both Gem and Rad GTPase crystal
structures are important first steps in this process [7-9].
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To assess the importance of Rem:CCT-PX association for Ca2+ channel regulation,
the ability of CCT-PX co-expression to relieve Rem-mediated current blockade was
examined. While expression of 3xHA-tagged CCT-PX in HIT-T15 cells did not cause
any significant changes to endogenous L-type Ca2+ channel activity (Figure 3.6A,B), coexpression of HA-CCT-PX was found to partially relieve Rem-dependent Ca2+ channel
inhibition (Figure 3.6C). A similar experimental approach was recently used to implicate
the importance of β-subunit association in Rem-mediated channel regulation [155]. Since
RGK-mediated Ca2+ channel regulation has been reported to be dose-dependent [156],
this recovery likely results from the partial disruption of the interaction between Rem and
the CCT of endogenous HIT-T15 Ca2+ channels by the exogenous CCT-PX peptide.
Taken together, these data support a crucial role for CCT-PX association in Remmediated Ca2+ channel regulation
Our studies also indicate that RGK proteins interact with the distal CCT when cooverexpresssed in tsA201 cells (Figures 3.1B, 3.4A, and3.4 B). Since there is only
limited sequence conservation within the CCT-DS domains among Cav1 and Cav2
channels (approximately 10% amino acid conservation within Cav1 and Cav2 channels)
[71], we suspected that Rem association might not involve a direct interaction. Indeed,
our inability to detect binding when mixing purified Rem and in vitro translated CCT-DS
(Figure 3.2B), strongly suggests that an additional intracellular factor(s) is required to
facilitate the association between Rem and CCT-DS. In skeletal and cardiac muscle, the
distal C-terminus of L-type calcium channels undergoes proteolytic cleavage [102, 186,
187], and the released distal fragment functions as an autoinhibitory domain [149, 150].
More recently, the CCT-DX domain has been reported to regulate gene transcription,
translocating to the nucleus in response to low Ca2+ concentrations [152]. Although the
CCT-DS has been reported to play important roles in regulating both channel activity and
gene expression [57, 152], our studies indicate that the CCT-DS domain is not required
for Rem-mediated L-type Ca2+ channel inhibition since Rem was still capable of
inhibiting Ca2+ channel function in a truncated channel lacking the CCT-DS domain
(Figure 3.5A). Phosphorylation of CaVα1 by cAMP-dependent protein kinase (PKA) leads
to enhanced Ca2+ current in cardiac myocytes [179] and Ser1928 has been identified as a
major target for PKA signaling [101] within the distal CCT. Although PKA inhibition
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partially relieves Rem-mediated L-type Ca2+ channel blockade [57], our studies indicate
that the phosphorylation of Ser1928 is not essential for directing Rem:CCT-DX association
(Figure 3.5B). Therefore, the CCT-DS does not appear to play an essential role in Remdependent L-type Ca2+ channel regulation.
Recent studies have suggested that both RGK-dependent CaVβ subunit association
[44, 46, 47, 55, 158] and HVA Ca2+ channel regulation are GTP-dependent processes.
For the majority of Ras family GTPases, the effector domain serves as the primary
interaction site for cellular binding proteins and this site is usually conserved within
subfamilies of Ras-related GTPases with similar physiological functions [1]. However,
the putative effector domains within the RGK proteins are poorly conserved [4, 8],
suggesting that this region is unlikely to direct binding to common cellular targets [163],
including both CaVβ-subunits and the CaVα1-CCT. While it is possible that individual
RGK proteins use distinct mechanisms to down-regulate HVA Ca2+ channel function, the
association of Rem and Rem2 with Cavβ has been found to be nucleotide-independent
[61, 155], proximal CCT binding does not require GTP-bound Rem (Figure 3.2B), and
Rem2-mediated inhibition of ICa,L in superior cervical ganglion neurons is nucleotideindependent [52]. Clearly, the GTP-dependence of RGK-mediated HVA Ca2+ channel
regulation, and the identification of the CaVβ and CCT binding domains within the RGK
GTPases will require further investigation.
In summary, we demonstrate here that RGK proteins are capable of interacting with
two distinct domains within the CaV1.2-CCT, including a direct interaction that requires
the CB/IQ domain within the proximal C-terminus. Furthermore, while plasma
membrane localization is necessary for Rem:CCT association and Ca2+ channel
regulation, it is dispensable for β subunit binding, suggesting that the Rem:CCT
interaction plays an important role in Rem-mediated HVA Ca2+ channel regulation.
These data, together with studies of RGK-CaVβ association [55, 56, 58, 155, 156, 162],
suggest a model in which CaVβ serves a scaffolding role, promoting formation of a stable
RGK-CaVβ-AID complex, which in turn interacts with the CB/IQ region of the CCT to
promote channel inhibition. This is reminiscent of recent models for Ca2+-dependent
inactivation (CDI) in which Ca2+-calmodulin binding to the CCT facilitates interaction of
the AID region with the proximal C-terminus of CaVα1 [138, 145]. Regulation of RGK-
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dependent Ca2+ channel inhibition appears to rely, in part, on the interaction of the
conserved RGK C-terminus with PIP membrane lipids [56, 61]. However, additional
studies will be needed to identify the cellular signaling pathways that control Remmediated HVA Ca2+ channel activity and the interplay between Rem:CCT and Rem:Cavβ
binding in Ca2+ channel inhibition.
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Figure 3.1 Rem interacts with both the proximal and distal domains of CCT
A Schematic of the CCT truncation mutants, the Rem interaction status is indicated on
the right. B, The ability of Rem to interact with two domains of the CCT was assessed by
co-immunoprecipitation. TsA201 cells were transiently co-transfected with expression
vectors encoding 3xFlag-tagged Rem and either PCDNA3.1+3xHAa (3xHA empty
vector), 3xHA-tagged CCT-FL or the indicated CCT truncation mutants. 48 h posttransfection, cells were harvested, and 0.5 mg cell lysate was subjected to
immunoprecipitation with anti-HA antibody as described in “Chapter 2”. The entire
bound fraction or 2.5 μl of the unbound fraction was analyzed by immunoblotting with
biotin-Flag to detect Rem. C, 5 μg cell lysate was immunoblotted with anti-HA to detect
CCT-FL and the corresponding truncation mutants used in Figure 3.1B. D, The ability of
Rem to interact with Cav3.2 CCT was assessed by co-immunoprecipitation. TsA201 cells
were transiently co-transfected with expression vectors encoding 3xFlag-tagged Rem and
either PCDNA3.1+3xHAa (3xHA empty vector), 3xHA-tagged Cav1.2 CCT or 3xHAtagged Cav3.2 CCT. Coimmunoprecipitation was performed with HA antibody as
described in B and interaction with Rem examined by immunoblotting with biotin-Flag
antibody. 5 μg cell lysate was immunoblotted with anti-Flag or anti-HA to determine the
expression level of Rem or Cav1.2 and Cav3.2 CCT, respectively.
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Figure 3.2 Rem interacts with CCT-PX in vitro
A, The indicated 35S-labeled CCT truncation mutants were prepared by in vitro
transcription and translation as described under “Experimental Procedures”. The 35Slabeled proteins were resolved on 10% SDS-PAGE gels, which were then dried and
exposed to film for 3 h. B, Recombinant GST or GST-Rem proteins coupled to GST
beads were preloaded with the indicated nucleotide, incubated with 35S-labeled CCT
truncation mutants for 3h at 4°C. The GST beads were then pelleted and washed as
described in “Chapter 2”. The bound fractions were subjected to SDS-PAGE, and the
dried gel was exposed to film for 16-72 h. C, Recombinant GST, GST-Rem, or GSTRem-(1-265) proteins coupled to GST beads were preloaded with GDP, incubated with
35
S-labeled CCT-FL or CCT-PX for 3 h at 4°C. The GST beads were then pelleted and
washed as described in “Chapter 2”. The bound fractions were subjected to SDS-PAGE,
and the dried gel was exposed to film for 24 h.
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Figure 3.3 CB-IQ domain is required for the interaction between CCT-PX and Rem.
A, Schematic of the CCT truncation mutants in the proximal domain, the Rem interaction
status is indicated on the right. B, Fine mapping of the Rem association domain within
CCT-PX was performed by co-immunoprecipitation. TsA201 cells expressing 3xFlagRem and either pCDNA3.1+3xHAa (3xHA empty vector) or the indicated 3xHA-tagged
CCT truncation mutants were subjected to anti-HA immunoprecipitation as described in
Figure 3.1. Rem association was determined by immunoblotting the bound fraction with
biotin-Flag antibody (top panel). 2.5 μl supernatant was immunoblotted with biotin-Flag
to detect Rem. 5 μg cell lysate was immunoblotted with anti-HA to determine the
expression level of CCT truncation mutants (bottom panel).
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Figure 3.4 Rem2 and Rad interact with both of the proximal and distal domains of
CCT
A, The interaction of Rem2 and Rad with CCT was assessed by co-immunoprecipitation
analysis. TsA201 cells were transiently co-transfected with expression vectors encoding
3xFlag-tagged Rem2 and either pCDNA3.1+3xHAa (3xHA empty vector), 3xHA-tagged
CCT-FL or the indicated CCT truncation mutants. The ability of 3xFlag-tagged Rem2 to
interact with either CCT-FL or the indicated truncation mutants was determined by coimmunoprecipitation analysis as described in “Chapter 2”. 2.5 μl supernatant was
immunoblotted with biotin-Flag to detect unbound Rem2. 5 μg cell lysate was
immunoblotted with anti-HA to detect CCT-FL and the corresponding CCT truncation
mutants (bottom panel). B, TsA201 cells were transiently co-transfected with expression
vectors encoding 3xFlag-tagged Rad and either pCDNA3.1+3xHAa (3xHA empty
vector), 3xHA-tagged CCT-FL or the indicated CCT truncation mutants. Coimmunoprecipitation analysis was performed as described in A.
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Figure 3.5 CCT-DS is not essential for Rem-mediated L-type Ca2+ current inhibition
A, TsA201 cells were transfected with plasmids expressing Cav1.21-1905, β1b and either
GFP-Rem or unfused GFP as a control. Current was examined using the whole-cell patch
clamp configuration in the presence of 30 mM Ba2+. B, Phosphorylation of Ser1928 located
in CCT-DS domain is not required for Rem:CCT-DS association. TsA201 cells were
transiently co-transfected with expression vectors encoding 3xFlag-tagged Rem and
either pCDNA3.1+3xHAa (3xHA empty vector), 3xHA-tagged CCT-DS or 3xHA-tagged
CCT-DSS1928A. Coimmunoprecipitation was performed with HA antibody as described in
chapter 2 and interaction with Rem examined by immunoblotting with biotin-Flag
antibody. 5 μg cell lysate was immunoblotted with bio-Flag or anti-HA to determine the
expression level of Rem or CCT-DS/CCT-DSS1928A, respectively.
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Figure 3.6 Co-expression of CCT-PX partially recovers L-type current from Remmediated regulation in HIT-T15 cells.
A, Current-voltage relationships were determined as described in “Chapter 2” for HITT15 cells co-transfected with GFP+3xHA (filled triangles, n=9), GFP+3xHA-CCT-PX
(filled circles, n=6) or GFP+3xHA-CCT-MD (open squares, n=7) in the presence of 30
mM Ba2+. B, Current density at 15mV is displayed for experiments in Figure 3.6A.
There is no significant difference between the treatments. C. Current density at 15 mV
from HIT-T15 cells cotransfected with GFP+3xHA (n=9), GFP-Rem+3xHA (n=9), GFPRem+3xHA-CCT-PX (n=13), or GFP-Rem+3xHA-CCT-MD (n=15). The error bars
represent the standard error of the mean. Analysis of the results by student’s t test
revealed a significant difference between treatments denoted by single (P<0.05) or double
(P<0.00005) asterisks.

57

Figure 3.7 Plasma membrane targeting is essential for Rem:CCT association.
A, In order to determine whether plasma membrane targeting of Rem was necessary for
CCT interaction, co-immunoprecipitation studies were performed. TsA201 cells were
transiently co-transfected with plasmids expressing either 3xFlag-tagged Rem, Rem-(1265), Rem-(1-265)-KCAAX, or Rem-(1-265)-HCAAX and either empty
PCDNA3.1+3xHAa vector control or 3xHA-tagged CCT-PX. Co-immunoprecipitation
was performed with HA antibody as described in “Chapter 2.” 5 μg cell lysate was
immunoblotted with anti-Flag or anti-HA to determine the expression level of Rem
proteins or CCT-PX, respectively. B, TsA201 cells were transiently co-transfected with
plasmids expressing either 3xFlag-tagged Rem-(1-265)-HCAAX or Rem-(1-265)HSAAX and either empty pCDNA3.1+3xHAa vector control or 3xHA-tagged CCT-FL.
Co-immunoprecipitation was performed with HA antibody as described in A. C, TsA201
cells were transiently co-transfected with plasmids expressing either 3xHA-tagged Rem(1-265)-HCAAX or Rem-(1-265)-HSAAX and either empty PCMVT7/F2 vector control
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or Flag-tagged β1b. Co-immunoprecipitation was performed with Flag antibody as
described in “Chapter 2” and interaction with Rem proteins examined by immunoblotting
with biotinylated HA antibody. Immunoprecipitates were blotted for β1b using
biotinylated Flag antibody. 5 μg cell lysate was immunoblotted with anti-HA to
determine the expression level of Rem. D. TsA201 cells were transfected with plasmids
expressing Cav1.2, β1b and either GFP-Rem-(1-265)-HCAAX, GFP-Rem-(1-265)HSAAX, or unfused GFP as control. Current was examined using the whole-cell patch
clamp configuration in the presence of 30 mM Ba2+.
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Figure 3.8 Localization of green fluorescent protein (GFP)-Rem-(1-265)-HCAAX
and GFP-Rem-(1-265)-HSAAX.
TsA201 cells were transfected with plasmids expressing GFP-Rem-(1-265)-HCAAX or
GFP-Rem-(1-265)-HSAAX. 48 h post transfection cells were examined by confocal
microscopy. Note that Rem-(1-265)-HCAAX is enriched at the cell periphery, which is
consistent with plasma membrane localization. However, Rem-(1-265)-SCAAX displays
predominant cytosolic localization.
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Chapter 4. Ca2+/CaM mediates Rem:CCT interaction
4.1 Introduction
As discussed in the last chapter, deletion mapping studies indicated that Rem
directly associates with a region around the CB-IQ region in the CCT-PX (Figure 3.3),
which is known to contribute to both Ca2+-dependent inactivation (CDI) and Ca2+dependent facilitation (CDF) through interaction with Ca2+-bound calmodulin [128, 129,
138, 148, 188]. Since overexpression of a Ca2+ insensitive CaM mutant disrupts CDI in a
“dominant-negative manner”, Ca2+-free CaM (ApoCaM) has been proposed to bind CCTPX constitutively [128, 129, 132]. Three different sequences within the Cav1.2 Cterminus have been suggested to contribute to ApoCaM or Ca2+/CaM binding and
regulation, designated A, CB and IQ [138, 188]. At resting Ca2+ level, Apo-CaM is
proposed to bind CCT-PX, although the exact binding domain is controversial; it is
recognized that upon channel opening, the influx of Ca2+ binds CaM tethered at the CCTPX very rapidly and initiates a conformational change within the CCT-PX domain. This
process triggers the development of CDI and the rapid shutdown of channels [138]. A
recent study by Pitt and colleagues suggests that Ca2+ -bound CaM elicits a
conformational change within the Cav1.2 C-terminus which promotes its interaction with
the α1C I-II intracellular linker, resulting in channel inactivation [145]. Indeed, mutation
of the isoleucine to a glutamate within the IQ domain (IQ to EQ) dramatically disrupts
CaM binding and abolishes both CDI and CDF [129]. Mutations of other residues in the
IQ domain which disrupt IQ:CaM association also prevent CDI [131]. While it is still
under debate whether IQ motif is involved in ApoCaM binding [138, 140, 141], A, CB
and IQ motif have all been implicated in the tethering of Ca2+-CaM [137, 142-144],
although the exact binding sites and conformations formed by Ca2+/CaM and CCT appear
to be dependent on the functional status of the channel [138]. Considering the essential
role of CB-IQ domain in CaM binding and the development of CDI, it is important to
determine whether the interaction between Ca2+-bound CaM and the CB-IQ domain
affects Rem:CCT-PX association and vice versa. If there is an interplay between
Rem:CB-IQ association and CaM:CB-IQ association, it would be very important to
determine if Rem alters the inactivation kinetics of CDI. In this chapter, we report that
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Ca2+/CaM disrupts Rem:CCT-PX binding in vitro, and that this activity is not due to
direct CaM binding to the Rem C-terminus. Interestingly, overexpresssion of CaM
partially relieves Rem-mediated L-type calcium channel inhibition and at the same time
Rem/CaM co-expression slows the kinetics of CDI, indicating that Rem and Ca2+/CaM
are likely competitors for CB-IQ binding and that Rem, and other RGK proteins, may
function at endogenous levels of expression as regulators of the kinetics of Ca2+ channel
inactivation, rather than as complete inhibitors of channel activity.
Dr. Robert N. Correll from our lab generated the electrophysiological data for
Cav1.2+β2a+GFP-Rem-(1-265)-HCAAX+PKH3-CaM shown in Figure 4.4E. I generated
all of the rest of data shown in Figure 4.1, 4.2, 4.3, 4.4, 4.5, 4.6 and 4.7.

4.2 Results
4.2.1 Ca2+/CaM inhibits Rem:CCT interaction in vitro
As described in chapter 3, both CaM and Rem are able to bind CCT-PX near the
CB-IQ region (Figure 3.3) [138], and CaM is known to associate with the Rem Cterminus in a Ca2+-dependent manner [44, 159]. Therefore, we reasoned that CaM may
have an effect on Rem:CB-IQ binding. Since we have previously shown that Rem
directly interacts with CCT-PX in a nucleotide independent manner (Figure 3.2B), we
used GST-Rem fusion protein to pull down

35

S-labeled CCT-FL or CCT-PX in the

presence or absence of exogenous CaM. We first tested whether high concentrations of
Ca2+ or EGTA would affect Rem:CCT binding without adding exogenous CaM to the
pulldown assay. Compared with GST-Rem:CCT-FL binding in the presence of 5 mM
EGTA (Figure 4.1, top panel, lane 4), the binding between Rem and CCT-FL was
modestly decreased by the addition of 2 mM Ca2+ (Figure 4.1, top panel, lane 2).
However, while the addition of CaM to the binding reaction had no obvious effect on
Rem:CCT-FL association in the presence of EGTA (Figure 4.1, top panel, lane 8), the
interaction between Rem and CCT-FL was almost completely inhibited upon the addition
of 2 mM Ca2+ (Figure 4.1, top panel, lane 6). The same study using GST-Rem and CCTPX yielded similar results (Figure 4.1, bottom panel). The fact that exogenous CaM
disrupted Rem:CCT binding only in the presence of Ca2+ suggests that it is Ca2+-bound
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CaM that serves to disrupt Rem:CCT association. This result also suggests that direct
Ca2+-CaM binding to CCT or Rem serves to block Rem:CCT association. The decrease in
Rem:CCT association in the presence of high concentrations of Ca2+ without the addition
of exogenous CaM is likely due to the presence of small amounts of CaM within the
reticulocyte (immature red blood cells) lysate used to generate the in vitro translated
CCT-FL or CCT-PX proteins.
We next asked whether high concentrations of Ca2+ disrupts Rem:CCT association
when Rem and CCT are co-overexpressed in TsA201 cells. For these studies, the binding
of 3xHA-tagged CCT-PX to 3xFlag-tagged Rem in the presence of saturating Ca2+ or
EGTA was determined using co-immunoprecipitaion followed by immunoblot analysis.
As seen in Figure 4.2, although Rem displayed binding with CCT-PX in the presence of 5
mM EGTA (Figure 4.2, top panel, lane 4), the binding between Rem and CCT-PX was
dramatically decreased in the presence of 2 mM Ca2+ (Figure 4.2, top panel, lane 2).
Transfected cells expressed similar levels of Rem and CCT-PX (Figure 4.2, middle and
bottom panel), indicating that the loss of binding between Rem and CCT-PX was not the
result of Ca2+-dependent proteolysis or a transfection artifact. Addition of exogenous
CaM did not affect the relative binding affinity between Rem and CCT either in the
presence of 2 mM Ca2+ or in the presence of 5 mM EGTA (data not shown), likely
because sufficient endogenous CaM is expressed in the tsA201 cells to be saturating. In
summary, Ca2+/CaM inhibits Rem and CCT association in TsA201 cells.
4.2.2 Ca2+/CaM mediated-Rem:CCT association is not due to Ca2+/CaM binding to
the Rem C-terminus
Since Ca2+/CaM is known to interact with both the CB-IQ domain and regions prior
to the CB-IQ within the CCT to modulate channel auto-regulation [137, 138, 142-144],
and the Rem C-terminus interacts with CaM in a Ca2+-dependent manner [44, 56, 159],
we next asked whether Ca2+/CaM-mediated blockade of Rem:CCT association is the
result of Ca2+/CaM binding to the CCT-PX or the Rem C-terminus. In order to
distinguish between these two possibilities, we made use of two chimeric proteins in
which the C-terminus of K-Ras4B and H-Ras were fused to Rem-(1-265), which were
described in chapter 3 [56]. Whereas the K-Ras4B-CAAX motif shares several properties
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with the Rem C-terminus, including a polybasic domain capable of PI lipid-meditated
plasma membrane targeting and calmodulin association [60, 189, 190], the H-Ras-CAAX
domain contains a prenylation/palmitoylation membrane localization signal and does not
bind CaM [189]. Previous studies found that fusion of the CAAX motif from either KRas4B or H-Ras to the C-terminal truncation mutant Rem-(1-265), restored membrane
localization and L-type Ca2+ channel regulation [56]. In chapter 3 we demonstrated that
while Rem-(1-265) fails to associate with the CCT-PX, fusion of the CAAX motif from
K-Ras4B or H-Ras to Rem-(1-265) C-terminus restored Rem:CCT-PX binding (Figure
3.7A). In order to examine whether Rem-(1-265)-KCAAX or Rem-(1-265)-HCAAX
binds to Ca2+/CaM, tsA201 cells were transfected with mammalian expression vectors
encoding either 3xFlag-Rem, 3xFlag-Rem-(1-265), 3xFlag-Rem-(1-265)-KCAAX,
3xFlag-Rem-(1-265)-HCAAX, or empty p3xFlag-CMV-10 vector as a control, and
lysates from these cells were subjected to CaM sepharose pulldown. As shown in Figure
4.3A, only WT-Rem and Rem-(1-265)-KCAAX displayed CaM binding, consistent with
our previously published work, CaM binding was disrupted by truncation of the Rem Cterminus [56]. Rem-(1-265)-HCAAX did not show Ca2+/CaM binding, which is also
consistent with the previous studies indicating that H-Ras does not bind CaM [189].
We next examined whether high concentrations of Ca2+ still disrupted the interaction
between CCT-PX and Rem-(1-265)-KCAAX or Rem-(1-265)-HCAAX. As seen in
Figure 4.3B, Rem, Rem-(1-265)-KCAAX, and Rem-(1-265)-HCAAX were all capable of
CCT-PX binding in the absence of Ca2+ (Figure 4.3B, lanes 2, 4 and 6), but did not
associate with CCT-PX in the presence of 2 mM Ca2+ (Figure 4.3B, lanes 1,3,and 5).
These data indicate that the Ca2+/CaM mediated blockade of Rem:CCT association is not
due to Ca2+/CaM binding to the Rem C-terminus.
4.2.3 Overexpression of CaM partially recovers L-type current from Rem-mediated
inhibition in tsA201 cells
Since Ca2+/CaM-mediated Rem:CCT association is not due to Ca2+/CaM binding to
the Rem C-terminus (Figure 4.3), we reasoned that Ca2+/CaM competes with Rem for
CCT-PX binding. CCT association appears to play an important role in Rem-mediated
channel regulation (Figure 3.6), and we reasoned that saturating levels of CaM should
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compete with Rem for CCT-PX binding, resulting in at least partial relief of Remmediated channel inhibition. In order to test this hypothesis, we next examined the effect
of CaM overexpression on Rem-dependent channel regulation in transfected tsA201
cells. We first evaluated the effect of CaM overexpression using 30 mM Ba2+ as the
charge carrier. Peak currents elicited from tsA201 cells expressing Cav1.2+FLAGβ2a+GFP+pKH3-CaM (Figure 4.4A, black square, -18.6±6.1 pA/pF, n=11 and Figure
4.4C) were not significantly different from those obtained in the absence of co-expressed
CaM [Cav1.2+FLAG-β2a+GFP+pKH3] (Figure 4.4A, green diamond, -12.3±2.4 pA/pF,
n=11 and Figure 4.4C), indicating that CaM overexpression alone does not modulate Ltype Ca2+ channel current density. Overexpression of CaM did not alter the relationship
between the IBa density and test pulse potential (Figure 4.4A). Unsurprisingly, coexpression of GFP-Rem was capable of generating complete current blockade in the
presence of 30 mM Ba2+ (Figure 4.4A, black unfilled circle, -0.3±0.4 pA/pF, n=6 and
Figure 4.4C). Importantly, co-expression of pKH3-CaM was able to partially relieve
Rem-mediated blockade of L-type ionic current (Figure 4.4 A, C). In these experiments,
CaM overexpression resulted in peak current densities of >3.5 pA/pF (Figure 4.4A, red
triangle, -3.6±1.2 pA/pF, n=12 and Figure 4.4C), which is ~19% of the peak current
density elicited in the absence of Rem overexpression. Although the average peak current
densities generated from Cav1.2+FLAG-β2a+GFP-Rem+pKH3 and Cav1.2+FLAGβ2a+GFP-Rem+pKH3-CaM transfection were not found to be statistically different, 7 out
of 12 cells transfected by Cav1.2+FLAG-β2a+GFP-Rem+pKH3-CaM generated
detectable Ca2+ current (peak current density < -1.5 pA/pF) while only 1 out of 6 cells
transfected by Cav1.2+FLAG-β2a+GFP-Rem+pKH3 generated detectable Ca2+ current
(peak current density = -2.3 pA/pF). We next tested the effect of CaM overexpression on
Rem-mediated channel inhibition using 30 mM Ca2+ as the charge carrier. Peak current
density elicited from the overexpression of Cav1.2+FLAG-β2a+GFP+pKH3-CaM (Figure
4.4B, green circle, -6.9±1.6 pA/pF, n=20 and Figure 4.4D) was not statistically different
from those seen following the overexpression of Cav1.2+FLAG-β2a+GFP+pKH3 (Figure
4.4B, black square, -6.3±1.9 PA/pF, n=11 and Figure 4.4D), suggesting that CaM
overexpression alone does not modulate L-type Ca2+ channel current density.
Overexpression of CaM also did not alter the relationship between the ICa density and test
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pulse potential (Figure 4.4B). As expected, co-expression of GFP-Rem resulted in a
complete blockade of current expression in this system (Figure 4.4B, black triangle, 0.1±0.2 pA/pF, n=8 and Figure 4.4D). However, co-expression of Rem and pKH3-CaM
resulted in >3 pA/pF peak inward current (Figure 4.4B, red diamond, -3.0±0.7 pA/pF,
n=16 and Figure 4.4D), which was found to be significantly different from the average
current density elicited from the Cav1.2+FLAG-β2a+GFP-Rem+pKH3 transfection
(Figure 4.4D) (p<0.01, Kruskal-Wallis test followed by a post hoc Dunn’s test). Thus,
expression of CaM results in a partial restoration of ICa,L, with CaM co-expression
generating 43% of the peak current elicited in 30 mM Ca2+ in the absence of Rem (Figure
4.4B and 4.4D).
In order to examine whether CaM-modulated Ca2+ current recovery is due to
Ca2+/CaM binding to the Rem C-terminus, we overexpressed GFP-Rem-(1-265)HCAAX, a chimeric Rem protein which is unable to bind Ca2+/CaM (Figure 4.3A), but is
capable of potent channel inhibition [56], with pKH3-CaM in tsA201 cells. Consistent
with our previously published work [56], GFP- Rem-(1-265)-HCAAX potently reduced
ionic current when co-expressed with Cav1.2+FLAG-β2a+pKH3 in tsA201 cells (Figure
4.4E, black unfilled squares, -0.7±0.4 pA/pF, n=8). However, whole cell peak currents
elicited in the presence of pKH3-CaM and GFP-Rem-(1-265)-HCAAX (Figure 4.4E, red
diamond, -6.0±1.8 pA/pF, n=10) were indistinguishable from currents elicited following
the expression of Cav1.2+FLAG-β2a+GFP+pKH3-CaM in 30 mM Ca2+ (Figure 4.4E,
green circle, -6.9±1.6 pA/pF, n=20). These data suggest that CaM-modulated Ca2+
current recovery from Rem blockade is not due to Ca2+/CaM binding to the Rem Cterminus. Although we do not have a straightforward way to measure the expression
levels of Rem and Ca2+ channel subunits in individual cell, the average expression levels
detected from whole cell lystes indicate that overexpression of CaM does not alter the
expression level of Rem or channel subunits (Figure 4.5). In summary, CaM
overexpression partially relieves Rem-mediated L-type Ca2+ current inhibition with either
Ba2+ or Ca2+ as the charge carrier.
4.2.4 Rem alters the kinetics of calcium-dependent channel inactivation
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It is well established that Ca2+/CaM binding to the CCT triggers the generation of
CDI [138]. Since Rem has also been shown to interact with the CCT-PX around the CBIQ domain and overexpression of CaM partially relieves Rem-mediated L-type Ca2+
channel inhibition (Figure 4.4A, B), we next asked whether Rem alters the kinetics of
voltage-dependent inactivation (VDI) or calcium-dependent inactivation. Figure 4.6A
shows the superimposed representative time course of the IBa generated during 300 ms
test pulses to +5 mV from Vh=-80 mV (holding potential) from the indicated transfection
experiments; all of the current traces were normalized in order to facilitate the kinetics
comparison. At 600 ms after the onset of the depolarization, ∼70% of the peak current
remains for Cav1.2+FLAG-β2a+GFP+pKH3 transfection, and neither CaM nor GFP-Rem
has an effect on inactivation kinetics of VDI (Figure 4.6C). Figure 4.6B shows the
superimposed representative time course of the ICa generated during 300 ms test pulses to
+20 mV from Vh=-80 mV (holding potential) from the indicated transfection
experiments. In order to examine the effect of overexpressed CaM or Rem on the
inactivation kinetics of CDI, individual traces of current elicited from different
experimental conditions in the presence of 30 mM Ca2+ were fitted with a doubleexponential equation as described in Chapter 2 and the time constants of inactivation
(tau) were then derived (Figure 4.6D). The value of taufast provides a way to determine
the rate of Ca2+-dependent inactivation. As seen in Figure 4.6D, expression of CaM in
tsA201 cells did not alter the inactivation kinetics for CaV1.2+FLAG-β2a in the
depolarizing potentials between 0 mV to 40 mV, which is consistent with previous
studies [126, 128]. However, inactivation kinetics following overexpression of
Cav1.2+Flag-β2a+GFP-Rem+pKH3-CaM displayed a statistically significant difference at
depolarizing potentials from 0 mV to 30 mV (* P<0.05; ** P<0.00005; Student’s t-test).
Indeed, the average taufast value increased following Rem and CaM co-expression (Figure
4.6D, red circles, 63.59±4.49 ms, n=8) by 64% when compared to cells expressing CaM
alone (Figure 4.6D, black squares, 38.83±2.11 ms, n=12) at 20 mV, which is the
depolarizing potential corresponding to the peak current. Since the average peak current
density derived from the overexpression of Rem and CaM is about 43% of the peak
current elicited in the absence of Rem, we plotted the inactivation constant taufast against
the peak current density measured at 20 mV from individual cells in the presence or the

67

absence of Rem overexpression (Figure 4.7) and compared the values of taufast from these
two conditions in a similar range of peak current density values. As seen in Figure 4.7, 7
out of 8 individual values of taufast derived from the transfection of Cav1.2+FLAGβ2a+GFP-Rem+pKH3-CaM were larger than those derived from the transfection of
Cav1.2+FLAG-β2a+GFP+pKH3-CaM (<10pA/pF), demonstrating that the significant
difference in inactivation kinetics between the two experimental conditions is not due to a
difference in average current densities. The difference in inactivation kinetics seen
following Rem and CaM co-expression argues that Rem alters the kinetics of Ca2+/CaMmediated channel inactivation by altering the rate of CDI. In summary, overexpression of
Rem significantly slows the inactivation kinetics of CDI, indicating that Rem coexpression modulates the process of Ca2+-dependent channel inactivation.

4.3 Discussion
In this chapter, we provide additional data to substantiate the importance of the
Rem:CCT interaction to Rem-mediated L-type Ca2+ channel regulation by demonstrating
an interplay between Rem:CCT-PX association and Ca2+/CaM:CCT-PX binding. First of
all, we demonstrate that Ca2+/CaM inhibits Rem:CCT-PX association in vitro (Figure 4.1
and 4.2). While CaM has been shown to interact with the RGK C-terminus in a Ca2+dependent manner [17, 46, 55, 159, 191], this association appears to be critical for Gem
and Rad [44, 55], but not for Rem [44, 159] and Rem2 [46]-mediated Ca2+ channel
inhibition. The reason for this discrepancy is not clear, although the ability of CaM-free
Rem and Rad to sequester Cavβ subunits in the nuclear has been proposed to be the
mechanism [44]. While Ca2+/CaM is capable of inhibiting Rem:CCT association, this
inhibition does not appear to rely upon Ca2+/CaM binding to the Rem C-terminus since
the chimeric CaM binding null protein Rem-(1-265)-HCAAX is also subject to
Ca2+/CaM regulation (Figure 4.3B). This is further supported by our electrophysiology
studies in which CaM overexpression completely blocked Rem-(1-265)-HCAAXmediated L-type Ca2+ channel inhibition when Ca2+ was used as the charge carrier
(Figure 4.4E). Consistent with previous studies [44, 159], these results indicate that
Ca2+/CaM binding to the Rem C-terminus is not essential for Rem-mediated calcium
channel inhibition.
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Since Ca2+/CaM has been shown to disrupt Rem:CCT-PX binding in vitro (Figure
4.1 and 4.2), it was hypothesized that CaM overexpression would relieve Rem-mediated
VDCC inhibition. Indeed, CaM overexpression was shown to partially reverse Remmediated L-type Ca2+ channel inhibition when either Ba2+ or Ca2+ was used as the charge
carrier (Figure 4A, B). It is surprising that CaM overexpression also partially relieved
Rem-mediated channel inhibition in 30 mM Ba2+ since high Ca2+ concentrations are
required to disrupt in vitro Rem:CCT association (Figure 4.1, 4.2). The fact that CaM
overexpression did not significantly increase the current density (Figure 4.4A, B, C and
D), or alter the kinetics of CDI (Figure 4.6B, D), suggests that endogenous CaM is not
limiting with regard to supporting the generation of functional Ca2+ channels in tsA201
cells. However, upon Rem overexpression, the expression of additional exogenous CaM
is required to generate partial current recovery (Figure 4.4A, B). It is possible that a
threshold concentration of CaM is required to disrupt Rem:CCT binding, which is only
achieved by overexpressing CaM in the presence of overexpressed Rem.
Since the CB-IQ region is implicated in CDI, and CaM overexpression partially
reversed Rem inhibition, we examined the effect of Rem on CDI. Interestingly, it was
found that co-expression of Rem slows the kinetics of CDI (Figure 4.6B, D), indicating
that Rem interacts with CCT and modulates the process of Ca2+/CaM-mediated CDI upon
overexpression in our systems. This is likely because Rem:CCT binding interferes with
Ca2+/CaM:CCT binding and the Ca2+/CaM-mediated conformational change within the
CCT domain which is required for the generation of CDI. Furthermore, in addition to the
CCT-PX region, Ca2+/CaM has also been shown to interact with the N-terminus [125,
146, 192] of the L-type Cavα1 subunit and this interaction also contributes to the
generation of CDI [125]. Additional studies will be necessary to determine whether the
N-terminus of Cavα1 subunit also interacts with Rem and contributes to Rem-mediated
channel regulation, if this is the case, then whether overexpression of Rem alters the
interaction between Ca2+/CaM and this region. Although there is no definitive data to
support this hypothesis, our studies suggest that a likely physiological role of RGK
proteins is to alter the kinetics of Ca2+ channel inactivation.
Our studies indicated that Rem overexpression partially inhibits Ca2+ current
amplitude in the presence of overexpressed CaM (Figure 4.4A, B) and slows the
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inactivation kinetics of CDI (Figure 4.6B, D). Since these two processes affect the
integrated Ca2+ influx in opposing way, if the former process predominates, the overall
Ca2+ influx would be decreased; on the other hand, if the latter process predominates, the
overall Ca2+ influx would be increased. In other words, RKG proteins could function as
channel inhibitors or channel activators. Whether this actually occurs under normal
physiological conditions is not addressed by the experiments in this chapter. However,
our studies suggest the possibility that RGK proteins may serve to stimulate Ca2+ currents
under physiological conditions, and the observed channel inhibition may be an artifact of
overexpression resulting from a cellular imbalance between Rem and CaM.
It has been reported that levels of Rad mRNA and protein are decreased
significantly in failing human hearts and that Rad expression is decreased significantly in
murine cardiac hypertrophy models [10], suggesting that Rad may play an important role
in maintaining normal cardiac function. However, whether endogenous L-type calcium
channel function is altered and whether the kinetics of CDI is altered in the
cardiomyocytes of Rad knockout animals has not yet been examined. The generation of
additional RGK knockout animals will be needed to fully address these important
questions. If the physiological role of RGK proteins is to alter the kinetics of CDI, as
what we observed in Figure 4.6B, D for Rem GTPase, we would expect to see a change
in kinetics of CDI for the L-type Ca2+ channels in cardiomyocytes following RGK
silencing.
In summary, our studies indicate that there is an interplay between Rem:CCT
association and Ca2+/CaM:CCT association. More importantly, our studies also suggest
that instead of functioning as a complete inhibitor for VDCCs, Rem may act as an
endogenous regulator for Ca2+ channel inactivation to slow the shutdown of the Ca2+
channels and increase the integrated Ca2+ influx in normal physiology.

Copyright © Chunyan Pang 2008
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Figure 4.1 Ca2+/CaM inhibits Rem:CCT association in vitro.
Recombinant GST or GST-Rem proteins coupled to GST beads were preloaded with
GDP, incubated with 35S-labeled CCT-FL (top panel) or CCT-PX (bottom panel) in the
presence of 2 mM Ca2+ or 5 mM EGTA with or without adding of 2 μg CaM for 3 h at
4°C. The GST beads were then pelleted and washed as described in chapter 2. The bound
fractions were subjected to SDS-PAGE, and the dried gel was exposed to film for 16-72h.
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Figure 4.2 High concentration of Ca2+ inhibits Rem:CCT binding in a coovexpression system.
TsA201 cells were transiently co-transfected with expression vectors encoding 3xFlagtagged Rem and either pCDNA3.1+3xHAa (3xHA empty vector) or 3xHA-tagged CCTPX. 48 h post-transfection, cells were harvested, and 0.5 mg cell lysate was subjected to
immunoprecipitation with anti-HA antibody as described in chapter 2. The entire bound
fraction was analyzed by immunoblotting with biotin-Flag to detect Rem. 5 μg cell lysate
was immunoblotted with anti-Flag or anti-HA to determine the expression level of Rem
or CCT-PX, respectively.
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Figure 4.3 Ca2+/CaM-mediated Rem:CCT association is not due to Ca2+/CaM
binding to the Rem C-terminus.
A, TsA201 cells were transfected with plasmids expressing 3xFlag-Rem, 3xFlag-Rem-(1265), 3xFlag-Rem-(1-265)-KCAAX, 3xFlag-Rem-(1-265)-HCAAX or empty p3xFlagCMV-10 as a control. 1 mg of lysates were pulled down onto CaM-sepharose beads in
the presence of 2 mM CaCl2, proteins were released from the beads with two 20 μl
washes of assay buffer containing 5mM EGTA, and the ability of Rem WT, Rem
truncation, or Rem chimeric proteins to associate with CaM was examined by
immunoblotting with anti-Flag M2 monoclonal antibody. B, TsA201 cells were
transiently co-transfected with expression vectors encoding 3xHA-tagged CCT-PX and
3xFlag-tagged Rem, 3xFlag-tagged Rem-(1-265)-KCAAX, or 3xFlag-tagged Rem-(1265)-HCAAX. The ability of 3xHA-tagged CCT-PX to interact with either 3xFlag-Rem
or the indicated Rem chimeric proteins was determined by co-immunoprecipitation
analysis as described in chapter 2. 5 μg cell lysate was immunoblotted with anti-HA or
anti-Flag to detect CCT-PX or the indicated Rem proteins, respectively.
73
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Figure 4.4 Overexpression of CaM partially recovers L-type current from Remmediated inhibition in tsA201 cells.
A, TsA201 cells were transfected with the indicated plasmids, and the current was
examined in the presence of 30 mM Ba2+ using the whole-cell patch clamp configuration.
B, TsA201 cells were transfected with the indicated plasmids, and the current was
examined in the presence of 30 mM Ca2+ using the whole-cell patch clamp configuration.
C, Current density at +5 mV from A. A significant difference (p<0.01, Kruskal-Wallis
test followed by a post hoc Dunn’s test) between treatments is denoted by asterisk. D,
Current density at +20 mV from B. A significant difference (p<0.01, Kruskal-Wallis test
followed by a post hoc Dunn’s test) between treatments is denoted by asterisks. E, CaMmodulated Ca2+ current recovery from Rem blockade is not due to Ca2+/CaM binding to
the Rem C-terminus. TsA201 cells were transfected with the indicated plasmids, and the
current was examined in the presence of 30 mM Ca2+ using the whole-cell patch clamp
configuration.
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Figure 4.5 Overexpression of CaM does not change the average expression levels of
Ca2+ channel subunits or GFP-Rem.
TsA201 cells were transiently transfected with Cav1.2, Flag-β2a, GFP-Rem, and pKH3CaM or pKH3 as the control. 48 hrs after the transfection, cell lysate was immunoblotted
with anti-Cav1.2, biotin-Rem or anti-HA antibody to detect Cav1.2, GFP-Rem, or CaM
protein, respectively. Flag--β2a was detected by immunoprecipitating cell lysate using
anti-Flag coupled to protein G beads and then immunoblotting the released proteins with
biotin-Flag.
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Figure 4.6 Overexpression of Rem alters the kinetics of CDI.
A, Representative IBa traces recorded from tsA201 cells transfected with the indicated
plasmids for Vtest +5 mV. B, Representative ICa traces recorded from tsA201 cells
transfected with the indicated plasmids for Vtest +20 mV. C, Residual fraction of currents
(r600) remaining at the end of the test pulses for Vtest +5 mV in the presence of 30 mM
Ba2+. There are no significant differences among the different transfection conditions. D,
Overexpression of Rem slows the inactivation kinetics of CDI. During a 800 ms test
pulse to a series of depolarizing potentials ranging from 0 mV to 40 mV, the inactivation
time constant tau was measured by fitting the inactivating components of the current
traces to the following equation: i(t) =A1* exp( t /taufast) + A2 * exp( t/tauslow) + C. The
fast inactivation component taufast at the different transfection conditions are plotted
against the corresponding depolarizing potentials. The error bars represent the standard
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error of the mean. Analysis of the results by student’s t test revealed a significant
difference between treatments denoted by single (P<0.05) or double (P<0.00005)
asterisks. Statistics comparison are between the transfection of Cav1.2+FLAG-β2a+GFPRem+PKH3-CaM (red cycles) and the transfection of Cav1.2+FLAG-β2a+GFP+PKH3CaM (black squares).
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Figure 4.7 Relations between the fast component of the time constant of inactivation
(taufast) and peak current density for the transfection of Cav1.2+FLAG-β2a+GFPRem+PKH3-CaM and Cav1.2+FLAG-β2a+GFP+PKH3-CaM.
Taufast derived from fitting of individual traces of current as described in chapter 2 were
plotted against the peak current density measured at 20 mV obtained from the
overexpression of Cav1.2+FLAG-β2a+GFP-Rem+PKH3-CaM (red cycles) or the
overexpression of Cav1.2+FLAG-β2a+GFP+PKH3-CaM (black squares).
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Chapter 5. Summary and Future Studies
5.1 Summary of the major findings
5.1.1 Rem:CCT binding represents another important molecular determinant in
Rem-mediated L-type calcium channel regulation
When I started my project, our lab and others had shown that two molecular
determinants played important roles in RGK-mediated Ca2+ channel regulation. The first
was the involvement of RGK:Cavβ binding in RGK-mediated calcium channel regulation
[163]. All of the four isoforms of Cavβ subunits have been shown to be able to bind RGK
proteins [55, 57, 58, 155, 156, 158], and previous studies had indicated that RGK:Cavβ
binding was required to generate channel blockade [55, 57, 58, 158]. At least three lines
of evidence have been generated in support of this statement. First, although Rem
overexpression can partially inhibit L-type calcium current derived from the
overexpression of Cavα1 alone in HEK293 cells [57], complete inhibition of Ca2+ current
is observed when Cavβ subunit is co-overexpressed [57]. Secondly, the putative Rad
dominant-negative mutant RadS105N, which is unable to bind Cavβ subunit [158], can not
inhibit Ca2+ channel activity [158]. Finally, RGK proteins can not regulate the functions
of T-type channels [52, 58], which do not require accessory Cavβ subunits [71]. However,
studies from our group and others also indicated that Cavβ binding alone is not sufficient
to block the channel activity [56, 162], which led to the identification of the second
molecular determinant in channel inhibition: the targeting of RGK protein to the plasma
membrane [163]. Although RGK proteins do not contain canonical lipid modification
motif in their C-terminus [51], the polybasic residues located at their C-terminus have
been found to direct plasma membrane localization by interacting with negatively
charged PIP lipids [56, 60, 61]. The importance of plasma membrane localization in the
generation of channel inhibition is highlighted by the observation that RGK proteins fail
to inhibit channel function when they are localized to the cytosol following truncating
their C-terminus. Importantly, these C-terminal truncation mutant proteins are still
capable of interacting with Cavβ subunits [52, 56, 58, 162]; and the ability of the
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truncation mutants to inhibit channel function is restored by the addition of plasma
membrane-targeting motifs [52, 56, 162].
A recent study indicated that the phosphorylation status of Ser1928 within the
Cav1.2 C-terminus may affect Rem-mediated Ca2+ channel inhibition through a protein
kinase A signaling pathway [57], suggesting that the Cavα1 subunit may also contribute to
Rem-mediated channel regulation. We extended these findings by demonstrating a direct
interaction between Rem and CCT-PX (Figure 3.2B). As an important control, Rem does
not interact with the CCT from T-type channels (Figure 3.1D), which do not undergo
RGK-mediated channel regulation [52, 58]. Deletion mapping studies indicated that the
conserved CB-IQ domain is required for Rem:CCT-PX association (Figure 3.3B), a
region known to play an essential role in modulating channel self-regulation, including
CDI and CDF, through the interactions of Ca2+/CaM with this domain [128, 129, 131,
140, 148]. We also found that Rem is capable of binding both of the proximal and distal
CCT (Figure 3.1B), although CCT-DS is not essential for Rem-mediated channel
inhibition (Figure 3.5A). Moreover, similar binding patterns are conserved in another two
RGK proteins, Rem2 and Rad (Figure 3.4A, B); indicating that the CCT represents a
common binding partner for the RGK GTPase subfamily. Our studies have generated two
lines of evidence to support the importance of Rem:CCT-PX binding in the generation of
channel inhibition. First, overexpression of CCT-PX partially reversed Rem-mediated Ltype calcium channel inhibition in HIT-T15 cells (Figure 3.6C), presumably by
sequestering Rem from binding to the CCT domain in full-length Cavα1 within the mature
channel complex. Secondly, although Rem:Cavβ binding is dispensable for the plasma
membrane localization of Rem [56, 162] and channel inhibition [56, 162], Rem:CCT
binding is well correlated with membrane localization of Rem and more importantly,
with Ca2+ channel inhibition (Figure 3.7 and 3.8). Therefore, we propose that in addition
to Cavβ binding and plasma membrane localization, Rem binding to the CCT-PX near the
CB-IQ domain is also required for channel regulation (Figure 5.1A). Although our
studies suggest that Rem:CCT-PX binding may represent an unappreciated molecular
determinant which is also critical to Rem-mediated calcium channel regulation, direct
evidence in support of this hypothesis is lacking and requires additional investigation.
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The approach which can be used to examine this hypothesis will be discussed in section
5.2.1.
5.1.2 Ca2+/CaM mediates Rem:CCT association and Rem overexpression alters the
kinetics of calcium-dependent inactivation
Another important finding from these studies is that Ca2+/CaM may regulate
Rem:CCT association (Figures 4.1, 4.2). Both ApoCaM and Ca2+/CaM have been shown
to interact with CB-IQ region and regions near CB-IQ to modulate channel selfregulation, including CDI and CDF [128, 129, 131, 140, 148], two opposite processes in
terms of regulating channel activity [138]. The fact that ApocaM is pre-tethered to the
CCT-PX enables the rapid response of CaM to local changes in Ca2+ concentration [128].
Upon channel activation, Ca2+ fluxing into the cells binds to CaM preassociated within
CCT-PX [128, 137] and initiates channel inactivation in milliseconds [131]. In the resting
state, the cytosolic Ca2+ concentration in many cell types is thought to be around 100-200
nM [193-195]; Opening of the Ca2+ channel generates a spatial Ca2+ gradient, within a
few nanometers of the channel pore, the concentration of Ca2+ is estimated to be around
10-100 μM upon channel activation [196, 197]. Since CaM-mediated inhibition of
Rem:CCT association appears to depend upon high Ca2+ concentration in vitro (Figure
4.1), it will be important to determine whether channel activation alters Rem-mediated
regulation. This can be examined by titrating the expression levels of Rem in xenopus
oocyte, which has been shown to be feasible [156] and then test if the different levels of
channel activity mediate the Rem-dependent alteration in CDI. As shown in Figure 5.1A,
we proposed that when Ca2+ concentration near the ion pore is low (for example, at
resting state), Rem is able to interact with Cavβ which is tethered to the I-II loop of the
Cavα1 subunit and CCT-PX around the CB-IQ domain at the same time, the formation of
I-II loop/Cavβ/Rem/CCT is required to generate channel regulation. However, whether
Rem functions as a potent inhibitor for Ca2+ channel activity in native systems is
questionable since dramatic or complete inhibition is only observed upon Rem
overexpression. ApoCaM, however, is associated with CCT-PX including the domain A.
Whether CB-IQ domain is also involved in ApoCaM binding is not clear since the
involvement of IQ domain in ApoCaM association is controversial [138]. When Ca2+
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concentration near the ion pore is higher than a certain threshold, Ca2+ binds to the
ApoCaM which is preassociated with the CCT-PX and Ca2+-bound CaM initiates a
conformation change in the CCT domain. Since Ca2+/CaM has a higher affinity for CBIQ binding, it disrupts the Rem:CCT-PX association. In this process, Rem slows the
occurrence of Ca2+/CaM-mediated channel closing. Ca2+/CaM has also been shown to
interact with N-terminus of Cavα1 subunit [125, 146] and this association contributes to
the generation of CDI [125]. However, whether Rem alters the interaction between
Ca2+/CaM and the N-terminus of Cavα1 or whether there is an interaction between the Nterminus and C-terminus of Cavα1 is currently unkown. The following observations
provide more evidence to support the model illustrated in Figure 5.1B. Firstly,
overexpression of CaM partially recovered Rem-mediated Ca2+ channel inhibition
(Figure 4.4). Secondly, the kinetics of CDI mediated by Ca2+/CaM binding to CCT-PX
was altered in the presence of overexpressed Rem (Figure 4.6B, D), indicating that
Rem:CCT binding interferes with the Ca2+/CaM-mediated CCT association and the
ensuing conformational change in this region.
The hypothesis that Rem acts to modulate channel activation/inactivation, rather
than serving as an absolute inhibitor of Ca2+ channel activity is a radical departure from
all previous models of RGK-mediated channel control [25, 44, 46, 47, 52, 55, 57, 58,
155, 156, 158, 163]. While it is well established that RGK blocks ionic Ca2+ current upon
overexpression [163], it should be pointed out that overexpression may not be the best
way to investigate the physiological roles of RGK proteins (section 5.2.2). Furthermore,
although our data suggest that the existence of the two different functional states shown
in Figure 5.1, it does not consider the complex intracellular environment and does not
describe the physiological function of RGK proteins at endogenous expression levels.
Indeed, it remains to be established whether RGK proteins predominantly function as
endogenous inhibitors of Ca2+ channel activity, to modulate the kinetics of channel
gating, or to operate in a novel regulatory cascade. It would appear that at nonphysiological levels of expression, Rem may act as an inhibitor of channel activity, but
that restoration of a single binding partner, namely CaM, has the ability to profoundly
alter Rem-mediated channel regulation. In native systems, we suggest that it is necessary
to consider RGK proteins as regulators that modulate channel opening probability instead
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of absolute channel blockers, with the possibility that RGK GTPases may function to
alter the kinetics of channel inactivation. The examination of these notions will require
the generation of RGK knockout animals or RGK knockdown cells systems. Since if
endogenous levels of RGK proteins inhibit channel current amplitude or slow the kinetics
of channel inactivation for L-type Ca2+ channels, knockdown of RGK proteins in native
systems would increase the Ca2+ current amplitude or enhance the kinetics of channel
inactivation.
In summary, although it is not yet clear whether alteration of the kinetics of CDI
represents an important functional role for Rem in normal physiology, those studies point
out the possibility that there is dynamic interplay among Ca2+/CaM, CCT and Rem.
Instead of functioning as a complete inhibitor to suppress ionic current, Rem may act as
an endogenous regulator for channel inactivation machinery.

5.2 Future directions
5.2.1 To determine the detailed molecular mechanisms underling RGK-mediated
calcium channel regulation
In addition to Cavβ binding and plasma membrane localization of RGK GTPases,
our studies suggest that RGK:CCT binding is an important molecular determinant in
generating Ca2+ channel inhibition upon overexpression (Figure 3.6 and Figure 3.7).
However, the definitive evidence to support the essential role of Rem:CCT binding in
Rem-mediated channel regulation is still lacking. Further studies need to be performed in
order to confirm this hypothesis. The most direct experimental approach would be to
generate a CB-IQ/CCT domain mutant in the context of Cav1.2-(1-1905) that displays
normal channel function, but fails to associate with Rem. If this CaVα1 mutant is still
responsive to Rem-mediated Ca2+ current suppression, then Rem:CCT association is not
required for channel inhibition. However, if this mutant is resistant to Rem-mediated
inhibition, then it can be concluded that Rem:CCT association is likely critical to
generating channel inhibition. Since the CB-IQ domain plays essential roles in channel
function and mutation of single amino acid in this region can readily alter channel
inactivation kinetics [129, 145] or abolish Ca2+ ionic current [198], data generated from
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these mutation studies will need to be carefully controlled and interpreted with caution. A
similar approach can be used to generate a CCT binding null Rem mutant, which
maintains Cavβ binding and plasma localization, but fails to associate with CCT. Again, it
should be aware that mutations in Rem, especially in the core domain can also easily
destabilize or interfere with the proper folding of the protein, therefore, their nucleotidebinding properties and the ability to interact with other known binding partners should be
also examined.
Our data suggest that RGK proteins are subject to regulatory mechanisms to allow
control over their ability to modulate Ca2+ channel activity. However, little is known
concerning these potential regulatory pathways, and several questions must be addressed
before this important issue can be tackled. First, what is the molar ratio between RGK
proteins and L-type Ca2+ channel complex located at the plasma membrane in different
endogenous systems? A limitation to these studies is the lack of effective antibody
reagents, both toward the RGK GTPases, but also to many components of L-type
channels. Secondly, are RGK proteins constitutively tethered to the Cavβ subunits and do
they always reside with mature channel complexes at the plasma membrane? Thirdly,
what is the relationship between Rem:Cavβ binding and Rem:CCT binding? Although we
propose that Cavβ serves as a scaffolding molecule to promote the formation of a stable
RGK-Cavβ-AID complex, which in turn interacts with the CB/IQ region of the CCT to
promote channel regulation (Chapter 3.3), the definitive supporting data for this model is
still lacking. In addition to ApoCaM, Ca2+/CaM and Rem, Cavβ has also been
demonstrated to interact with the CB-IQ domain [199]. The fact that Rem/CCT-PX/Cavβ
can interact with each other greatly enhances the complexity of those interactions and
thwarts efforts to clarify the detailed molecular mechanisms underling those interactions.
The resolution of these questions may need extensive mapping studies facilitated by
mutagenesis analysis to generate mutants which lose binding to one of the partner but
maintain association to the other.
It has been shown that CaM interacts with additional intracellular domains of the
Cavα1 subunit in addition to the CCT, including the N-terminus [125, 146, 192] and the III loop [137] of the L-type Ca2+ channel α1 subunit. The possibility that CaM binding to
those regions contributes to the reversal of Rem-mediated channel inhibition needs to be
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investigated. Indeed, it remains to be determined whether any additional intracellular
domains of the Ca vα1 subunit in addition to CCT are capable of RGK binding.
5.2.2 To explore the physiological functional roles of RGK proteins in native systems
Although it is well established that RGK proteins function as potent negative
regulators to inhibit HVA Ca2+ channel activity upon overexpression in either native or
heterologous systems [25, 44, 46, 47, 52, 55, 57, 58, 155, 156, 158, 163], the
physiological roles of RGK proteins at normal expression levels in native systems remain
poorly understood. It must be pointed out that overexpression may not be the best
approach to studying the physiological role of RGK proteins in terms of Ca2+ channel
regulation for the following reasons. First, in native systems including heart, pancreas,
and brain where L-type calcium channels are expressed, those channels can be activated
properly in response to membrane depolarization although endogenous RGK proteins are
also expressed in those tissues. Thus, it appears that either RGK proteins are expressed at
cellular levels which do not allow association with all channel complexes, that secondary
regulatory processes limit the extent of Rem association with functional channels, or that
RGK proteins do not act as inhibitors of channel function, but instead play a more subtle
role perhaps by altering channel gating as suggested by our recent studies. Secondly, it
has been reported that RGK proteins inhibit Ca2+ current amplitude in a dose-dependent
manner [156]. The fact that increasing expression levels of RGK proteins result in
decreasing Ca2+ ionic current suggests that in native systems, RGK activity may be
inhibited by a negative regulator(s). Overexpression of RGK proteins may saturate this
regulatory factor(s), which leads to complete inhibition of the channel activity seen in the
overexpression studies. Recent studies using transgenic mice, especially Rad transgenic
mice have started to demonstrate the physiological functions of RGK proteins. Rad
knockout mice have been generated and those mice were found more susceptible to
cardiac hypertrophy, possibly correlated with increased CaMKII activity in their
cardiomyocytes [10]. However, this study failed to examine cardiomyocytes using EP
methodology, and it will be important to determine whether Rad loss affects the
inactivation kinetics of L-type calcium channels. Since CaMKII can regulate the
extraction-contraction coupling in the heart [200], in part through enhancing Ca2+ current
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by binding to CCT-PX involving the CB-IQ region through a process named calciumdependent facilitation (CDF) [148, 201, 202], it will also be interesting to examine
whether RGK proteins and CaMKII compete for CCT-PX binding and if RGK can alter
CDF. Transgenic mice overexpressing dominant-negative mutant of Rad displayed a long
QT interval and demonstrated increased propensity for diverse forms of arrhythmias
under both resting and stimulated conditions [11], indicating that Rad, and maybe other
RGK proteins, play very important roles in maintaining normal cardiomyocyte function.
Although increased numbers of Cavα1 subunits at the plasma membrane in the ventricular
cardiomyocytes of the dominant-negative Rad transgenic mice has been suggested to
contribute to the altered cardiac function [11], the detailed molecular mechanisms that
underlie this increased Ca2+ channel activity await more investigation.
Although our studies indicate that Rem might involve in alter the kinetics of CDI
(Figure 4.6B, D), whether it represents the physiological role of RGK proteins is still not
understood. If the physiological role of RGK proteins is just to slow down the kinetics of
CDI, then in the simplest model, RGK proteins are actually functioning as Ca2+ channel
activators instead of inhibitors by increasing the channel mean opening time. However, it
is also possible that RGK proteins decrease the opening probability of Ca2+ channel, or
that different RGK protein will have distinct effects on channel gating. Indeed, a recent
report indicates that Rem2, but not Gem or Rem, accelerates the inactivation kinetics of
L-type Ca2+ channels [156].. Therefore, it will be important to characterize the ability of
the individual members of the RGK family to alter channel gating, and also to determine
whether the composition of the channel complex may contribute to the nature of the
regulation. Since four different subtypes of L-type Ca2+ channels and four different β
subunits (β1-β4) have been identified [71], it will be necessary to determine if RGK
proteins alter the channel gating in a similar way for the different combinations of Cavα1
and Cavβ subunits.
In summary, we report here that CCT-PX serves as another common binding partner
for RGK GTPases (Figure 3.1, 3.4), and also demonstrate the importance of Rem:CCTPX binding in generating Rem-mediated L-type Ca2+ channel inhibition (Figure 3.6, 3.7).
Furthermore, our in vitro studies suggest that Ca2+/CaM may regulate Rem:CCT binding
(Figure 4.1, 4.2). More importantly, our studies suggested that instead of functioning as
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inhibitors for Ca2+ channel function, RGK proteins may serve as endogenous regulators
for Ca2+ channel inactivation machinery (Figure 4.6). Therefore, these studies provide
new insight into the mechanism of RGK-mediated Ca2+ channel regulation and have
potentially revealed a novel physiological role of the RGK proteins.

Copyright © Chunyan Pang 2008
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Figure 5.1 Proposed mechanisms for Rem-mediated L-type Ca2+ channel regulation.
A, when Ca2+ concentration near the ion pore is low, Rem is capable of interacting with
Cavβ subunit tethered to the I-II loop of the Cavα1 subunit and also interacts with the
CB/IQ region of the CCT at the same time. It is questionable whether the formation of III loop/Cavβ/Rem/CCT complex is required to generate channel inhibition in normal
physiology. ApoCaM is associated with CCT-PX including the domain A. Whether CBIQ domain is also involved in ApoCaM binding is not clear since conflicting data have
been generated in terms of the involvement of IQ domain in ApoCaM association. B,
When Ca2+ concentration near the ion pore reaches a certain threshold; Ca2+ binds to the
ApoCaM which is preassociated with the CCT-PX and this binding initiates a
conformation change in the CCT domain. Since Ca2+/CaM has a higher affinity for CBIQ binding, it disrupts the Rem:CCT-PX association. This process slows the kinetics of
CDI and prolongs the mean opening time of the channel. Ca2+/CaM has also been shown
to interact with N-terminus of Cavα1 subunit and this association also contributes to the
generation of CDI for L-type Ca2+ channels. Recently, Ca2+/CaM has been proposed to
bridge the N- and C-terminus of Cavα1 to trigger the generation of CDI [125]. However,
whether Rem alters the interaction between Ca2+/CaM and N-terminus of Cavα1 or
whether there is an interaction between N-terminus and C-terminus of Cavα1 is unknown.
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Appendix: List of Abbreviations
AID
AKAP
ApoCaM
ATP
CaVα
CaVβ
CaM
CaMKII
CCT
CCT-DS
CCT-MD
CCT-PX
CDF
CDI
DTT
EDTA
EGTA
GAP
GDP
GEF
GFP
GST
GTP
GTPase
GTPγS
HA
HVA
PCR
PIP
PKA
PKC
PP1
PP2A
RGK
SDS-PAGE
VDCC
VDI

Cavα1 loop I-II interaction domain
A kinase anchoring protein
Ca2+-free Calmodulin
Adenosine triphosphate
VDCC alpha subunit
VDCC beta subunit
Calmodulin
Ca2+/calmodulin-dependent kinase II
Cavα1 subunit C-terminus
Distal Cavα1 subunit C-terminus
Medial domain of Cavα1 subunit C-terminus
Proximal Cavα1 subunit C-terminus
Calcium-dependent facilitation
Calcium-dependent inactivation
Dithiothreitol
Ethylenediaminetetraacetic acid
Ethylene glycol tetraacetic acid
GTPase activating protein
Guanosine diphosphate
Guanine nucleotide exchange factor
Green fluorescent protein
Glutathione-S-transferase
Guanosine triphosphate
Guanosine triphosphatase
Guanosine 5’-3-O-(thio)triphosphate
Hemagglutinin
High-voltage activated
Polymerase chain reaction
Phosphorylated phosphatidylinositide lipids
Protein kinase A
Protein kinase C
Protein phosphatase 1
Protein phosphatase 2A
Rem, Rem2, Rad, and Gem/Kir GTPases
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
Voltage-dependent calcium channel
Voltage-dependent inactivation
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